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Abstract 
Mycobacterium tuberculosis, the causative agent of Tuberculosis (TB), is notorious for 
its ability to persist during infection and evade the host immune response, although the 
cellular mechanisms behind this are not yet fully understood. Like other mycobacteria, 
M. tuberculosis produces the cofactor F420 found in Actinobacteria and Archaea, which 
is important, through unknown mechanisms, for its survival during oxidative stress and 
in the reactivation of latent infection. This project presents the characterisation of the 
largest F420 utilizing protein family in mycobacteria known as the flavin/deazaflavin 
dependent oxidoreductases (FDORs), forming the basis for identifying potential 
functional roles of these enzymes that might contribute to mycobacterial infection and 
persistence.  
While most FDORs in mycobacteria utilise F420 as a cofactor, this family also includes 
proteins with other cofactor specificities, including proteins that utilise FMN, FAD and 
heme. Five novel FDOR structures are presented, which, along with previously 
available structures, allowed the identification of conserved motifs to differentiate 
between FDORs with different cofactor specificities. Comparisons between the 
structures also showed that FDORs have relatively conserved cofactor-binding regions, 
while the substrate binding pockets are extensively modified for functional adaptation. 
Their cofactor preference, sequence similarity and structures allowed the classification 
of the FDORs into functional groups, including the previously identified F420H2-
dependent quinone reductases that also activate 4-nitroimidazole pro-drugs approved for 
treating multi-drug resistant M. tuberculosis infection. For the first time, mycobacterial 
heme oxygenases belonging to this family were also found, along with novel FAD 
binding proteins that could be involved in the hypoxia response that triggers 
mycobacterial dormancy. Furthermore, in silico substrate docking led to the 
identification of novel F420H2-dependent fatty acid saturases and F420H2-dependent 
biliverdin reductases (F-BVRs) within the FDORs. 
Detailed characterisation of the F-BVR Rv2074 from M. tuberculosis showed that its 
homologues are present in pathogenic and commensal mycobacteria and that it reduces 
biliverdin-IXα (the principle isomer produced by human macrophages) to bilirubin-IXα. 
Bilirubin is a potent antioxidant that could contribute to M. tuberculosis surviving 
oxidative stress encountered inside macrophages.  Rv2074 reduces biliverdin by a 
6 
 
mechanism similar to the nicotinamide-dependent reactions in the mammalian 
biliverdin reductases as inferred using the structure of the Rv2074:F420 complex with 
biliverdin modelled into the active site. Proton donation to a pyrrole nitrogen occurs 
first from a hydroxonium ion stabilised by an arginine residue, which is consistent with 
the requirement for an alternate proton donor since F420H2 appears to be stabilised in its 
deprotonated state when bound to FDORs. The resulting cationic intermediate 
undergoes hydride transfer with F420H2, completing bilirubin formation. 
Lastly, F420 production was found to be more widespread than in just Actinobacteria and 
Archaea, with data confirming F420 production in some Proteobacteria and Chloroflexi, 
which also encode the proteins required for its biosynthesis. FDORs are also present in 
these organisms, implying their capability of utilising this rare cofactor as well. 
Overall, the work described in this thesis highlights the diversity of the FDORs and has 
identified functional roles that could contribute to M. tuberculosis pathogenesis and 
persistence by enhancing survival during oxidative stress. 
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1.1 Introduction 
Mycobacterium tuberculosis, the causative agent of Tuberculosis (TB), is responsible 
for more deaths than any other pathogen in recorded history, currently killing over 1.5 
million out of 10 million people diagnosed each year (WHO 2015). As it is highly 
contagious and airborne, a third of the world’s population is thought to carry latent 
infection which usually becomes active upon immune compromisation, such as in 
individuals with HIV infection, diabetes or malnutrition (WHO 2015). The ability of 
mycobacteria to persist in an inactive dormant state requires treatment with long courses 
of antibiotics (Jain et al. 2008). However, poor compliance to  treatment regimens along 
with the impermeability of dormant mycobacteria causes exposure to sub-optimal drug 
doses, which has led to the emergence of multi- and total- drug resistant strains 
(Gillespie 2002; Jain et al. 2008; Velayati et al. 2009; Udwadia et al. 2012). The 
prevalence of these strains creates an urgent need to understand the underlying 
mechanisms behind the persistence of this bacterium and develop novel drug targets 
(WHO 2015). 
The deazaflavin cofactor F420 is produced in large quantities in mycobacteria including 
M. tuberculosis. It has only been isolated from Actinobacteria and Archaea and is 
structurally related to the riboflavin based cofactors flavin mononucleotide (FMN) and 
flavin adenine dinucleotide (FAD) (Greening, Ahmed et al. 2016). However, its 
chemistry is more similar to that of the nicotinamide cofactors NAD+ and NADP+ 
where it undergoes obligate 2-electron hydride transfer reactions (Greening, Ahmed et 
al. 2016). 
F420 is required for mycobacterial persistence since its production increases resistance to 
oxidative and nitrosative stress and is also required for reactivation from latency 
(Purwantini & Mukhopadhyay 2009; Hasan et al. 2010; Gurumurthy et al. 2013). 
However, the underlying F420-dependent mechanisms that are involved in these 
processes are not very well understood. It is known that F420 is reduced to F420H2 in 
mycobacteria by the F420-dependent glucose 6-phosphate dehydrogenase (Fgd) 
(Purwantini & Daniels 1998), and that the F420H2 produced can react with nitrosative 
species (Hasan et al. 2010). In pathogenic mycobacteria, F420 is also required to oxidise 
mycolic acids to ketomycolic acids by the F420-reducing hydroxymycolic acid 
dehydrogenase (fHMAD) (Purwantini & Mukhopadhyay 2013). Ketomycolic acids 
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maintain the integrity and impermeability of the cell envelope that increases resilience 
to oxidative stress and are critical for virulence (Yuan et al. 1998; Dubnau et al. 2000).      
Apart from these enzymes, the largest known F420 utilising protein family in 
mycobacteria that could perform persistence related functions are the flavin/deazaflavin 
dependent oxidoreductases (FDORs) (Singh et al. 2008; Taylor et al. 2010; Lapalikar et 
al. 2012a; Gurumurthy et al. 2013). These enzymes use F420H2 to reduce a variety of 
compounds, including quinones required for cellular respiration (Gurumurthy et al. 
2013) and coumarin-derived substrates like aflatoxins that contaminate soils (Taylor et 
al. 2010; Lapalikar 2012a). An FDOR named the deazaflavin dependent nitroreductase 
(Ddn) is also responsible for the activation of 4-nitroimidazole prodrugs like delamanid 
in M. tuberculosis (Singh et al. 2008), that are the newest class of antibiotics to be 
accepted for use against multi- and total- drug resistant strains (Blair & Scott 2015). 
Each Mycobacterium species can contain as many as 30 homologues of FDORs, most 
of which are functionally uncharacterised (Taylor et al. 2010). They can broadly be 
divided into two groups, FDOR-As and FDOR-Bs (Taylor et al. 2010), where it is the 
FDOR-As that have been shown to have physiologically relevant quinone, aflatoxin and 
4-nitroimidazole reductase activities (Taylor et al. 2010; Lapalikar et al. 2012a). The 
structural characterisation of FDORs revealed a split β-barrel fold (Taylor et al. 2010; 
Cellitti et al. 2012; Mashalidis et al. 2015), similar to the ubiquitously found 
pyridoxamine-5’-phosphate oxidases (PnPOxs) that utilise the related flavin cofactor 
FMN (Safo et al. 2000). Proteins with this same protein fold are also known to bind 
alternative cofactors including FAD (Hilario et al. 2012) and heme (Jiang et al. 2009) in 
other bacteria. A deeper understanding of the functions of the FDORs will be 
instrumental in identifying the functional roles of F420, why its production is retained in 
mycobacteria and how this protein superfamily of mostly uncharacterised proteins 
contributes to mycobacterial persistence. 
1.2 Research objectives 
The broad aim of this project was to investigate the reasons for the abundance of 
FDORs in mycobacteria and how this relates to their catalytic function. Phylogenetic 
methods were used to re-classify these proteins based on their cofactor preferences and 
five new FDOR structures solved using X-ray crystallography are presented to explore 
the structural basis for functional adaption in this family. During this project novel 
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FDOR functions in mycobacteria were identified, including a new class of F420H2-
dependent biliverdin reductases, and initial work in characterising the reaction 
mechanism of these proteins are presented that utilises a mix of computational and 
biochemical methods. Lastly, the importance of F420 in the broader bacterial community 
was explored by showing the abundance of F420 producing organisms beyond 
Actinobacteria and Archaea, alluding to the possible importance of F420-dependent 
FDORs in these bacteria. 
1.3 Research outline 
This thesis presents three published articles and two manuscripts in review, each 
presented as its own Chapter. The bulk of the work exploring the main aim of the 
research is presented as a single published article in chapter 3. Each chapter contains an 
introduction explaining the background and relevance of the research for the thesis and 
a summary of the key finding and implications, where detailed research discussion is 
provided in the manuscripts themselves. The chapters are organised as follows: 
Chapter 2 is a detailed literature review on deazaflavin cofactors, their properties, 
physiological roles and catalytic functions in Archaea and Actinobacteria. The most 
relevant sections for the thesis are highlighted. 
Chapter 3 classifies FDORs into functional groups, identifies novel functions within 
these proteins and presents 4 new FDOR structures from Mycobacterium smegmatis, 
namely MSMEG_2027, MSMEG_6519, MSMEG_4975 and MSMEG_5243. 
Chapter 4 identifies the protonation state of F420 in the prodrug activating FDOR 
Rv3547 (Ddn) that forms the basis for studying the reactions catalysed by this cofactor 
in this superfamily. 
Chapter 5 characterises the newly identified F420H2-dependent biliverdin reductases by 
studying their reaction mechanism based on the presented structure of the M. 
tuberculosis FDOR Rv2074 complexed with F420. 
Chapter 6 examines the abundance of F420 production among other bacteria signifying 
the broader role of F420-dependent FDORs in these organisms. 
Chapter 7 is a general discussion of the findings from the presented research and how it 
reflects on the roles, catalytic mechanisms and evolution of F420 and FDORs in 
mycobacteria and other bacteria. 
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1.4 Experimental methods 
The main experimental methods used in the presented research are protein x-ray 
crystallography and phylogenetics with a particular emphasis on the use of the relatively 
new technique of protein sequence similarity networks (SSNs). Brief backgrounds on 
these methods are provided in the Appendix. Other techniques used include molecular 
biology, protein purification, enzyme assays using spectroscopy, mass spectrometry, 
small molecule nuclear magnetic resonance spectroscopy and in silico substrate 
modelling.   
1.5 Publications 
* represents co-first authorship 
Ahmed, F.H., Carr, P.D., Lee, B.M., Afriat-Jurnou, L., Mohamed, A.E., Hong, N.-S., 
Flanagan, J., Taylor, M.C., Greening, C. & Jackson, C.J., 2015. Sequence-Structure-
Function Classification of a Catalytically Diverse Oxidoreductase Superfamily in 
Mycobacteria. Journal of molecular biology, 427(22), pp.3554–3571. 
Greening, C.*, Ahmed, F.H.*, Mohamed, A.E., Lee, B.M., Pandey, G., Warden, A.C., 
Scott, C., Oakeshott, J.G., Taylor, M.C. & Jackson, C.J., 2016. F420- and Fo-dependent 
redox reactions: physiology, biochemistry, and applications. Microbiology and 
Molecular Biology Reviews, 80(2), pp.451-493. [Featured cover article] 
Mohamed, A.E., Ahmed, F.H., Arulmozhiraja, S., Lin, C.Y., Taylor, M.C., Krausz, 
E.R., Jackson, C.J. & Coote, M.L., 2016. Protonation state of F420H2 in the prodrug-
activating deazaflavin dependent nitroreductase (Ddn) from Mycobacterium 
tuberculosis. Molecular bioSystems, 12(4), pp.1110–1113. 
Ahmed F.H., Mohamed A.E., Carr P.D., Condic-Jurkic K., O’Mara M.L. & Jackson 
C.J., 2016. Rv2074 is a novel F420H2-dependent biliverdin reductase in Mycobacterium 
tuberculosis. Protein Science, 25(9), pp.1692–1709. [Featured article] 
Ney B.*, Ahmed F.H.*, Carere C.R., Biswas A., Warden A.C., Morales S.E., Pandey 
G., Watt S.J., Oakeshott J.G., Taylor M.C., Stott M.B., Jackson C.J. & Greening C., 
2016. The methanogenic redox cofactor F420 is widely synthesized by aerobic soil 
bacteria. The ISME Journal. doi:10.1038/ismej.2016.100. 
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1.6 Protein structure depositions 
The following structures solved during this project were deposited and accepted to the 
Protein Data Bank. 
Ahmed FH, Carr PD & Jackson CJ (2015). PDB ID: 4Y9I, Structure of F420-H2 
dependent reductase (FDOR-A) MSMEG_2027.  
Ahmed FH, Carr PD & Jackson CJ (2015). PDB ID: 4YBN, Structure of the FAD and 
heme binding protein MSMEG_4975 from Mycobacterium smegmatis.  
Ahmed FH, Carr PD & Jackson CJ (2015). PDB ID: 5BNC, Structure of heme binding 
protein MSMEG_6519 from Mycobacterium smegmatis.  
Lee BM, Carr PD, Ahmed FH, & Jackson CJ (2015). PDB ID: 4ZKY, Structure of F420 
binding protein, MSMEG_6526, from Mycobacterium smegmatis.  
Ahmed FH, Carr PD & Jackson CJ (2016). PDB ID: 5JAB, Structure of the biliverdin 
reductase Rv2074 from Mycobacterium tuberculosis in complex with F420.  
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2.1 Summary 
Most of the early work charactering F420 and F420 dependent proteins focussed on its 
utilisation in Archaea and roles in methanogenesis. While it had been known since the 
1960’s that mycobacteria synthesise a molecule with similar properties (Cousins 1960), 
it was the increased prevalence of drug resistance that first prompted further research 
into the role of this cofactor in a pathogenic species (Purwantini & Daniels 1996). This 
work initially focused on the F420-dependent glucose 6-phosphate dehydrogenase (Fgd) 
that produces the reduced form of the cofactor F420H2 (Purwantini & Daniels 1996), 
which could protect mycobacteria during infection by reacting with and quenching 
nitrosative species (Purwantini & Mukhopadhyay 2009). This was in agreement with 
work showing that F420 production makes mycobacteria more resistant towards 
oxidative stress (Guerra-Lopez et al. 2007; Hasan et al. 2010; Gurumurthy et al. 2013). 
In addition to Fgd, the related protein F420-reducing hydroxymycolic acid 
dehydrogenase (fHMAD) was found to contribute to maintaining the integrity of the 
cell wall of pathogenic species (Purwantini & Mukhopadhyay 2013), which is required 
for virulence (Dubnau et al. 2000).
 
Interest in the role of F420 in mycobacteria was also fuelled by the discovery that it is 
involved in the activation of 4-nitroimidazole prodrugs, which are the newest class of 
antibiotics to be approved for use against Mycobacterium tuberculosis (Stover et al. 
2000; Blair & Scott 2015). This led to the discovery and characterisation of the first 
F420H2-dependent flavin/deazaflavin dependent oxidoreductase (FDOR), which reduces 
4-nitroimidazoles to release nitrous oxide, causing mycobacterial cell death (Singh et al. 
2008; Cellitti et al. 2012). This enzyme was subsequently found to also be an F420H2-
dependent quinone reductase, which could protect mycobacteria against oxidative stress 
by reducing endogenous quinones to dihydroquinones, preventing the alternate pathway 
for the production of cytotoxic semiquinones (Gurumurthy et al. 2013). FDORs were 
also found to be involved in the degradation of aflatoxins (carcinogenic contaminant 
found on tropical food crops) and specific activities with different aflatoxin analogues 
and related coumarin-derived substrates were used to classify these proteins into the 
FDOR-A, FDOR-AA and FDOR-B sub-groups (Taylor et al. 2010; Lapalikar et al. 
2012a). Following this, the work presented in Chapter 3 further classified FDORs into 
functional groups and discovered the F420H2-dependent biliverdin reductases that could 
also protect mycobacteria against oxidative stress (Ahmed et al. 2015).  
  Chapter 2 – Literature review 
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In addition to these findings, which are specific to F420 in mycobacteria, a lot of other 
work has been published on F420 biosynthesis, its distribution, and roles in Archaea and 
other Actinobacteria. The need for a comprehensive review on the subject became 
increasingly clear, leading to the production and compilation of the work presented in 
this chapter. 
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2.2 Published Article 
F420- and Fo-dependent redox reactions: physiology, biochemistry, and applications 
Chris Greening*, F. Hafna Ahmed*, A. Elaaf Mohamed, Brendon M. Lee, Gunjan 
Pandey, Andrew C. Warden, Colin Scott, John G. Oakeshott, Matthew C. Taylor  
and Colin J. Jackson 
*CG and FHA contributed equally to this work 
Microbiology and Molecular Biology Reviews 2016, 80(2)   
 
Journal cover by FHA based on a concept by BML 
This paper has been peer-reviewed and published as a review article, and was written 
after the publication of the work presented in Chapter 3. It assembles the vast amount of 
sporadic information available on the deazaflavin cofactors and their utilisation. Dr. 
Chris Greening organised the manuscript and focused on the sections on archaeal and 
actinobacterial enzymes and their physiological relavence. I contributed early drafts on 
Fo and F420 biosynthesis, mycobacterial enzymes and their physiological roles, produced 
most of the figures and wrote or significantly edited all sections on enzyme structure 
and catalysis. Elaaf Mohamed researched and wrote the sections on the properties of Fo 
and F420, photoactivation of Fo, F420 mediated 4-nitroimidazole activation and produced 
Figures 4 and 20. Brendon Lee contributed research on tuberculosis treatment, produced 
Figure 15 and edited Figure 20. Gunjan Pandey, Warden, Colin Scott, John Oakeshott 
and Matthew Taylor edited and contributed research to the sections on methane 
mitigation, bioremediation and industrial biocatalysis and Colin Jackson significantly 
edited the content of the whole manuscript. 
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For the purposes of this thesis, the most relevant sections of the review are the 
following: 
1.  Introduction 
2.1 Properties 
2.2.1 Fo biosynthesis 
2.3  Cofactor F420 
4.1.1  Physiological roles in mycobacteria 
4.2.2  Fgd: F420-dependent glucose 6-phosphate dehydrogenase 
4.3.1  FDORs: Flavin/Deazaflavin oxidoreductase superfamily  
5.1  Tuberculosis treatment 
5.3  Bioremediation 
6.  Concluding remarks 
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3.1 Introduction 
The flavin/deazaflavin oxidoreductase (FDOR) superfamily was first described as a 
novel group of proteins in Mycobacterium smegmatis that utilise F420H2 to degrade 
carcinogenic aflatoxins found on food crops (Taylor et al. 2010). M. smegmatis has over 
30 different FDOR homologs and phylogenetic analysis revealed that these proteins 
belong to two main sub-groups FDOR-A and FDOR-B, that have about 30% sequence 
identity between them (Taylor et al. 2010). Their structural characterisation showed the 
same split β-barrel fold as the highly conserved pyridoxamine 5’-phoshphate oxidases 
(PnPOx) that utilise FMN as a cofactor (Taylor et al. 2010).  
To degrade aflatoxins, FDORs reduce the α,β-unsaturated lactone moiety, allowing 
them to also reduce other furanocoumarins like angelicin, imperatorin and 8-MOP 
(Taylor et al. 2010; Lapalikar et al. 2012a). The FDOR-As demonstrated a higher 
reductase activity with these substrates (Taylor et al. 2010), although a subset named 
FDOR-AAs exhibited no activity (Lapalikar et al. 2012a), implying alternative 
functional roles in vivo. In addition, the deazaflavin dependent nitroreductase (Ddn) 
from M. tuberculosis that reduce 4-nitroimidazole prodrugs also belongs to the FDOR-
As (Singh et al. 2008; Lapalikar et al. 2012a). The physiological role of Ddn and its 
homologues were later suggested to be reducing endogenous quinones to 
dihydroquinones (Gurumurthy et al. 2013). Together, these observations suggested a 
high degree of promiscuous substrate specificity within these enzymes and their 
plasticity was further emphasised when some FDORs were shown to be reductases with 
F420H2 and oxidases with FMN (Lapalikar et al. 2012b). Indeed, several proteins of 
unknown function with the split β-barrel domain are known to bind cofactors other than 
F420 and FMN, including FAD and heme (Hilario et al. 2012; Hu et al. 2011).  
The primary focus of this chapter is to identify the F420 binding FDORs from other 
related proteins and to classify FDORs based on function using available and new 
protein structures to look at cofactor and substrate interactions. This information would 
form the basis for further characterisation of these proteins in identifying their 
physiological roles in mycobacterial pathogens. It also presents preliminary functional 
characterisation of previously uncharacterised sub-groups, including novel F420H2-
dependent fatty acid saturases, F420H2-dependent biliverdin reductases, heme 
oxygenases and potential electron transfer proteins. 
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3.2 Published article 
Sequence-Structure-Function Classification of a Catalytically Diverse 
Oxidoreductase Superfamily in mycobacteria 
F. Hafna Ahmed, Paul D. Carr , Brendon M. Lee, Livnat Afriat-Jurnou,  
A. Elaaf Mohamed, Nan-Sook Hong, Jack Flanagan, Matthew C. Taylor,  
Chris Greening and Colin J. Jackson 
Journal of Molecular Biology 2015, 427: 3554-3571   
 
This paper was peer-reviewed and published as an original research article. I performed 
most of the experiments and analysis unless otherwise stated, including the protein 
purification, crystallography, assays, in-silico substrate docking and bioinformatic 
analysis. I also wrote the paper with the help of Chris Greening and Colin Jackson. Paul 
Carr collected the crystallography data and finalised the submitted structures. High-
throughput in-silico substrate docking was performed by Jack Flanagan and Brendon 
Lee analysed these results, crystallised and solved the structure of MSMEG_6526, 
performed lipid binding assays and some of the enzyme activity assays. Livnat Afriat-
Jurnou refined the enzyme assay techniques and helped with early FDOR classification. 
Elaaf Mohamed purified F420 with the help of Matt Taylor and helped design the 
spectroscopic assays and Nan-Sook Hong performed the cofactor binding assays for 
MSMEG_3380.  
The published supplementary material is provided following the manuscript. 
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Supplementary material 
 
 
S1 Fig. Phylogenetic tree of the FDORs from Mycobacteria. All proteins characterised in this work 
from M. smegmatis (MSMEG_) and M. tuberculosis (rv) are annotated, where the solved crystal 
structures (in this work and previously) are annotated in red.  
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S2 Fig. Abundance and conservation of FDORs in mycobacteria. Nodes from the SSN (Fig 2) were 
separated for cofactor specificity (FMN – yellow, FAD – orange, heme – red, non-specific – blue, not 
tested – grey) at a logE cut-off of -7.6. The F420 dependent proteins (green) were further separated at a 
logE cut-off of -28, where each cluster represents proteins with ~50% sequence identity. Black and pink 
triangles represent proteins characterized and structures solved in this study respectively. Blue triangles 
represent previously published structures. 
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S3 Fig. Ligand bound absorbance spectra of MSMEG_6519 and MSMEG_4975. A. Heme 
coordination to MSMEG_6519 and spectra of co-purified biliverdin. B. FAD and heme binding protein 
MSMEG_4975 and its reduction with sodium dithionite.  
 
 
 
 
 
S4 Table. Comparison of F420H2 dependent reductase activity by proteins in the FDOR-A1 sub-group 
substrate enzyme Km (µM) Kcat (s-1) Kcat/Km (s-1 M-1) 
Menadione 2027 23.4 ± 2.56 0.567 ± 0.009 2.42 × 104 
3356 8.67 ± 1.09 2.39 ± 0.04 2.76 × 105 
rv3547* 3.44 ± 1.27 0.295 ± 0.002 8.58 × 104 
PA-824 2027 nd nd nd 
3356 nd nd nd 
rv3547* 28.6 ± 3.55 0.078 ± 0.004 2.74 × 103 
* data from Gurumurthy et al. [1] 
Data are averaged from two independent experiments  ± standard error from the mean 
nd, no detected activity 
 
[1] M. Gurumurthy, M. Rao, T. Mukherjee, S.P.S. Rao, H.I. Boshoff, T. Dick, C.E. Barry, U.H. 
Manjunatha, A novel F420-dependent anti-oxidant mechanism protects Mycobacterium tuberculosis 
against oxidative stress and bactericidal agents, Mol. Microbiol. 8 (2013) 744–755. 
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S5 Table. Data collection and refinement statistics for crystallography. 
Crystal MSMEG_2027 MSMEG_4975 MSMEG_6526 MSMEG_6519 
PDB ID 4Y9I 4YBN 4ZKY 5BNC 
Data collection     
Space group  I1 2 1 C1 2 1 P 21 21 21 P 61 
Unit-cell parameters     
a (Å) 37.49 84.72 56.7 62.10 
b (Å) 36.85 59.88 59.42 62.10 
c (Å) 77.59 89.66 95.99 301.41 
α, β, γ (°) 90, 96.59, 90 90, 93.83, 90 90, 90, 90 90, 90, 120 
Wavelength (Å) 1.5418 0.9655 0.9537 0.9537 
Resolution range (Å)* 26.19-1.50 
(1.52-1.50) 
44.73-1.90 
(1.94-1.90) 
19.81-1.65 
(1.67-1.65) 
43.77-2.25 
(2.32-2.25) 
Unique reflections 16332 35306 39312 31095 
Completeness (%)* 95.6 (92.1) 99.6 (99.2) 98.3 (76.8) 99.9 (99.2) 
Multiplicity* 2.7 (2.7) 7.5 (7.6) 7.0 (3.9) 5.2 (3.2) 
Rmerge *# 0.062 (0.514) 0.101 (1.109) 0.057 (0.901) 0.097 (0.637) 
Rpim*^ 0.044 (0.369) 0.039 (0.428) 0.031 (0.667) 0.046 (0.417) 
Mean <I/σ(I)>* 13.0 (2.1) 13.0 (2.1) 21.3 (1.4) 14.1 (1.9) 
CC1/2*† 0.997 (0.699) 0.998 (0.760) 0.999 (.467) 0.996 (0.516) 
Molecules per 
asymmetric unit 
1 2 2 2 
solvent content (%, v/v) 41 45 51 56 
Refinement     
Reflections used 16330 33553 39257 29399 
Resolution range (Å)* 26.2-1.50  
(1.54-1.50) 
43.6-1.90  
(1.95-1.90) 
19.4-1.65  
(1.68 -1.65) 
43.8-2.25  
(2.31-2.25) 
Rwork / Rfree*‡ 0.155/0.199 
(0.267/0.334) 
0.176/0.223 
(0.274/0.313) 
0.222/0.259 
(0.324/0.362) 
0.185/0.230 
(0.282/0.332) 
Number of atoms (all) 1170 3805 2398 3989 
Water molecules 188 326 165 250 
Average B-factor (Å2)     
Main chains 10.3 30.2 29.7 31.4 
Side chains 13.6 36.5 33.0 35.7 
Water molecules 26.2 41.5 32.2 36.0 
FAD molecules - 39.9 - - 
Heme molecules - 35.1 - - 
R.M.S Deviations     
Bond Lengths (Å) 0.02 0.02 0.01 0.01 
Bond Angles (°) 1.91 1.90 1.11 1.77 
Chain A to B (Å) - 0.51 1.1 1.4 
Ramachandran plot 
regions (%) 
    
Favored  99.1 99.0 97.8 98.0 
Allowed  0.9 1.0 1.8 1.8 
Outliers 0 0 0.4 0.2 
*Values in parenthesis are for the highest-resolution shell 
#Rmerge = (Σh Σi |Ihi – Ih|) / (Σh Σi Ih) where Ih is the average intensity of i symmetry-related 
observations of the unique refection h. 
^Rpim = (Σh Σi (1/(nh – 1))1/2 |Ihi - Ih|) / (Σh Σi Ih) 
†CC1/2 = linear correlation coefficient between intensities from random half-datasets 
‡Rwork = Σh |F(obs) – F(calc)| / Σh |F(obs)| and 5% of the data that were excluded from the refinement were used 
to calculate Rfree. 
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S6 Table. Genomic context and co-occurrence analysis of AA1-AA3 subgroups 
 
[1] J.A. McGarvey, L.E. Bermudez, Phenotypic and Genomic Analyses of the Mycobacterium avium 
Complex Reveal Differences in Gastrointestinal Invasion and Genomic Composition, Infect. Immun. 69 
(2001) 7242–7249. 
 
 
 
 
 
Group Protein Associated protein Biological role/process of 
associated protein 
STRING 
score 
AA1 MSMEG_1981 MSMEG_1982  
(acyl coA synthetase) 
Fatty acid biosynthesis 0.520 
AA2 Rv1871c Rv0593  
(lipoprotein LprL) 
Found when searching for 
genes that are present in M. 
avium that may help invade 
intestinal mucosa [1]. LprL 
and LprK are membrane 
bound lipoproteins. 
0.860 
Rv0173  
(lipoprotein LprK) 
0.760 
AA3 MUL2188 Cut5 (cutinase) Cutin (fatty acid) hydrolysis, 
facilitates pathogenesis 
0.601 
Cut1 (cutinase) 0.488 
Cut4 (cutinase) 0.469 
Lppx (lipoprotein) Lipoprotein  0.561 
MUL_3253  
(lipid A biosynthesis 
lauroyl acyltransferase) 
Lipopolysaccharide synthesis 
for outer cell membrane 
0.475 
AA3 MSMEG_1077 MSMEG_1528 
(cutinase) 
Cutin (fatty acid) hydrolysis, 
facilitates pathogenesis 
0.530 
Cut3 (cutinase) 0.515 
MSMEG_1526 
(cutinase) 
0.485 
MSMEG_4465 
(cutinase) 
0.439 
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S7 Fig. Preliminary functional characterisation of the FDOR-AAs. A. Arachidonic reductase activity 
by MSMEG_1981 in the presence of 25 µM F 420H2 (Km = 113 ± 21 µM, Kcat = 5.4×10-4 ± 2.0 ×10-5 s-1, 
Kcat/Km = 4.8 M-1 s-1). B. Affinity for arachidonic acid by FDOR-AAs. 
 
 
S8 Table. Text representation of conserved motifs in FDORs  
No. Motif (regular expression) Role Group 
1 LT[TH]TG[RA]K[ST]G[KQ]PRxTP F420 binding All As and AAs 
2 P[DA]W[YV]RN[LV][RK]A[NA][PG]x[VA][TE][VLI] F420 binding All As and AAs 
3 [GD]R[YV][IV][VIL]V[AG]S[KN]GG[AR][PD]K[HN] F420  
and substrate 
binding 
All As 
4 EYQA[KR]T[DS]R[VQ]IP[VL][FV][VEI][LC] Substrate 
binding 
All As 
 V[TR]ARE[LAV]TG[DEA]ER[DA][RE]L[WL]  All As 
AA1, AA2 
5 L[AT]T[VLF][RT][PA]DGRP[HQ][LV][SVT]P[VI]W[F
Y]AV 
Cofactor 
binding 
All Bs 
 
6 SRK[VA]R[NR][IL]R[RA]DPR[VA][TSA][LVI] F420 binding B1-B6 
7 F[FS]T[HDN]A[GT]S[RAQ]K[GAV][RH][EQ][IL][AE][
HQ][NT]P[WR][AV][SA] 
FMN binding B9 
8 EG[KT]K[IL]EM[AIM][ER]AN[PDN][NR]V[CL][FIV][
ELT][AF]D 
FAD binding B8, B11 
9 [IL][YC][IV]Sx[IL]AEH[GY]RNL[EA]A[ND]PR[AV][S
D] 
heme binding B7 
 G[RW][YW][VL]S[VA][ED]G[TR]A[ET][VIL]xxD[PG][
AD]AV 
 B1-B4, B6, B8 
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S9 Text. Materials and Methods 
 
Cloning, expression and purification of proteins. All sequences for the FDOR-B related proteins were 
ordered as Gene Strings from Invitrogen, with additional 50 base pair flanking regions at each end, 
homologous to the multiple cloning site (Nde1 – EcoR1) of the target cloning vector pETMCSIII. The 
sequence at the 5’ end introduced a TEV protease cleavage site (GAGAACCTGTATTTTCAGGGT) 
between the His-tag and the N-terminus of the protein as well. These genes were amplified (forward 
primer: GTTTAATCGGATCCTAAGGAGGTTAATATTATG, reverse primer: GTTAGCAGCCG-
GATCTATCGATGCATGCCATGGTAC) and cloned into pETMCSIII using Gibson assembly 1. The 
genes for MSMEG_2027, MSMEG_3356 and the FDRAAs in the expression vector pDEST17 were 
generously provided by CSIRO 2. Truncated MSMEG_2027 (Δ26 amino acids at the N-terminus) for 
protein crystallography was also cloned into petMCSIII using the Nde1 and EcoR1 restriction sites. 
(forward primer: CAAATAGTCATATGGTGCACGTGCTGGACCG, reverse primer: 
CAAGAATTCCT-ATTCGACGATGAACACGGGGATC). 
 
The FDRAAs and MSMEG_3863 were purified using previously published methods 2. For the rest of the 
proteins, Escherichia coli strain BL21DE3 cells were transformed and starter cultures were grown in TB 
media containing 0.5% glucose at 37 °C. After 6 hours, the starter cultures were transferred to and grown 
overnight at 25-30 °C in 1 L of modified auto-induction TB media 3, containing 5 g yeast extract, 20 g 
tryptone, 85.5 mM NaCl, 22 mM KH2PO4, 42 mM Na2HPO4, 0.6% glycerol, 0.05% glucose, 0.2% lactose 
and 100 µg/ml Ampicillin. Cell pellets were harvested by centrifugation at 5000 × g for 15 min at 4 °C, 
resuspended in 30 mL of lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 25 mM imidazole, pH 8) and 
lysed by sonication using an Omni Sonicator Ruptor 400 (3 × 3 min at 60% power). The soluble fraction 
was separated by further centrifugation at 13000 × g for 1 hr at 4 °C and the lysate was passed onto a 
Qiagen or GE NiNTA column, where the purified protein was eluted with the same buffer containing an 
additional 250 mM imidazole.  
 
An additional step was performed before elution for the MSMEG_5243 and MSMEG_5675 prepared for 
cofactor binding assays. The flavin co-purified with the protein was stripped by partial on-column protein 
refolding 4, which involved washing with buffer containing 50 mM NaH2PO4, 300 mM NaCl, 2 M urea 
and 2 M KBr at pH 6.5. The eluted samples were dialyzed into 50 mM Tris-HCl, 200 mM NaCl, pH 8 
and stored at 4°C. Proteins used for crystallography were further purified by cleaving off the His-tag with 
TEV protease (expressed and purified in-house) and removing it by a second pass through the NiNTA 
column. They were then further purified by size exclusion chromatography using a GE Hiload 16/600 
Superdex 75 pg column, and the final sample was concentrated to 1.3 mM (~30 mg/mL) in buffer 
containing 20 mM HEPES, 50 mM NaCl, pH 7.5. 
 
Protein crystallography. High-throughput screens from Hampton Research were used to identify initial 
crystal forming conditions for MSMEG_2027, MSMEG_6526, MSMEG_6519 as well as cofactor-bound 
MSMEG_4975. Truncated MSMEG_2027 (NΔ26) was used since the full-length protein failed to 
crystallize, similar to what was observed for the closely related protein rv3547 5. Refined conditions for 
the crystals used for data collection were as follows: MSMEG_2027 = 20% PEGMME5000, 0.05 M 
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imidazole pH 6.7; MSMEG_4975 = 25 % PEG4000, 0.2 M ammonium sulfate, 0.1 M sodium acetate pH 
4.6; MSMEG_6526 = 0.2 M sodium iodide, 22% PEG3350; and MSMEG_6519 = 0.2 M magnesium 
acetate, 0.1M HEPES pH 7.5 and 23% PEG3350. 
 
Data for MSMEG_2027 was collected in house (Xenocs GeniX 3D Cu HF microbeam X-ray generator, 
MAR345 plate detector) and MSMEG_4975, MSMEG_6526 and MSMEG_6519 were collected at the 
Australian Synchrotron (beamline MX1 and detector ADSC Q210r for MSMEG_6519, beamline MX2 
and detector ADSC Q315r for MSMEG_4975 and MSMEG_6526). Crystals were cryo-cooled under a 
stream of 100K nitrogen gas in the following cryobuffers: MSMEG_2027 - 35% PEGMME5000, 0.05 M 
imidazole pH 6.7, 500 µM FMN; MSMEG_4975 - 35 % PEG4000, 0.2 M ammonium sulfate, 0.1 M 
sodium acetate pH 4.6; MSMEG_6526 - 0.2 M sodium iodide, 22% PEG3350, 13% ethylene glycol; 
MSMEG_6519 - 0.2 M magnesium acetate, 0.1M HEPES pH 7.5 and 24% PEG3350, 11% ethylene 
glycol. Diffraction data were integrated using XDS 6, and the CCP4 suite 7 was used for scaling using 
AIMLESS 8, followed by molecular replacement using Phaser 9. The structures 3R5Z 5 3FHK,2FUR, 
4QVB 10 and 2ARZ were obtain phases for MSMEG_2027, MSMEG_5243, MSMEG_4975, 
MSMEG_6526 and MSMEG_6519 respectively. Model building was performed using Buccaneer 11 and 
ARP/wARP 12 followed by manual loop building in Coot 13. Interspersed refinements were done using 
Refmac 14 and PHENIX 15. Local non-crystallographic symmetry restraints were used for the refinement 
of MSMEG_4975, MSMEG_6519 and MSMEG_6526. A difference (mFo – dFc) omit map for FAD and 
heme in MSMEG_4975 was generated by refining the structure with the ligands removed (restrained 
refinement with no prior phase information using Refmac 14). 
 
 
1. Gibson, D. G., Young, L., Chuang, R.-Y., Venter, J. C., Hutchison, C. A. & Smith, H. O. (2009). 
Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Meth 6, 343-345. 
2. Lapalikar, G. V., Taylor, M. C., Warden, A. C., Scott, C., Russell, R. J. & Oakeshott, J. G. 
(2012). F420-H2-Dependent Degradation of Aflatoxin and other Furanocoumarins Is Widespread 
throughout the Actinomycetales. PLoS One 7, e30114. 
3. Tartof, K. D. & Hobbs, C. A. (1987). Improved media for growing plasmid and cosmid clones. 
Focus 9. 
4. Hefti, M. H., Milder, F. J., Boeren, S., Vervoort, J. & van Berkel, W. J. H. (2003). A His-tag 
based immobilization method for the preparation and reconstitution of apoflavoproteins. 
Biochimica et Biophysica Acta (BBA) - General Subjects 1619, 139-143. 
5. Cellitti, Susan E., Shaffer, J., Jones, David H., Mukherjee, T., Gurumurthy, M., Bursulaya, B., 
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Structure of Ddn, the Deazaflavin-Dependent Nitroreductase from Mycobacterium tuberculosis 
Involved in Bioreductive Activation of PA-824. Structure 20, 101-112. 
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8. Evans, P. R. & Murshudov, G. N. (2013). How good are my data and what is the resolution? 
Acta Crystallographica Section D 69, 1204-1214. 
9. McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. & Read, R. 
J. (2007). Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674. 
10. Mashalidis, E. H., Gittis, A. G., Tomczak, A., Abell, C., Barry, C. E. & Garboczi, D. N. (2015). 
Molecular insights into the binding of coenzyme F420 to the conserved protein Rv1155 from 
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3.3 Structure of the FAD binding protein MSMEG_5243 
This structure was part of the early manuscript but was removed to streamline the story. 
MSMEG_5243 belongs to the large FAD binding mycobacterial FDOR family (FDOR-
B8) that has not been previously characterised (Ahmed et al. 2015). This section 
summarises work on its preliminary functional characterisation. 
A recent study indicated that the gene encoding MSMEG_5243 is part of the DosR 
(dormancy survival regulator) regulon in M. smegmatis (Berney et al. 2014). DosR is 
activated by the redox sensor DosS and oxygen sensor DosT, and in turn activates the 
transcription of ~50 genes during the transition of mycobacteria from growth to 
persistence following oxygen-deprivation (Boon & Dick 2002; Park et al. 2003). 
Analysis of microarray data reveals that MSMEG_5243 is also strongly upregulated 
during hypoxic conditions (Berney & Cook 2010). The genomic location of the B8 
proteins is highly conserved in pathogenic mycobacteria as well, including M. 
tuberculosis (Figure 2.1), suggesting a role in hypoxia adaptation. 
 
Figure 3.1. Conserved genomic context of msmeg_5243 in pathogenic 
mycobacteria. usp – “universal stress protein” of unknown function, dosR – hypoxia 
induced transcription regulator, tgs - diacylglycerol acetyltransferases, dosS/T – heme 
binding histidine kinase-like hypoxia/redox sensor. 
To investigate in more detail, the crystal structure of MSMEG_5243 was solved to 2.7 
Å resolution (Table 2.1). The protein, which co-purified with FAD, was prepared with 
the histidine-tag removed as detailed in Text S9 of the manuscript (Ahmed et al. 2015). 
The crystallisation buffer and cryobuffer composition was 20% polyethylene glycol 
1500, 4% 2-methyl-2,4-pentanediol and 0.1 M citric acid pH 3.5. Data was collected in 
house (Xenocs GeniX 3D Cu HF microbeam X-ray generator, MAR345 plate detector) 
and data processing and refinement was also performed as in Text S9 (Ahmed et al. 
2015). Data and coordinate files are provided in the electronic version of this thesis. 
rv3132c
MSMEG_
5241
MUL2422
dosS/T
rv3130c
MSMEG_
5242
tgs
M. tuberculosis
M. avium
M. smegmatis
M. ulcerans
rv3129
MAV4110
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MUL2418
rv3133c
MAV4109
MSMEG_
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MUL2423
dosR
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MUL2424
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MUL2420
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Table 1. Crystallography statistics for MSMEG_5243 
Data collection  Refinement  
Space group P2 21 21 Reflections used 81938 
Unit-cell parameters  Resolution range (Å)* 29.6-2.69 (2.72-2.69) 
a (Å) 80.27 Rwork / Rfree*‡ 0.216/0.254 (0.313/0.374) 
b (Å) 186.04 No. of atoms (all) 20558 
c (Å) 195.39 Water molecules 372 
α, β, γ (°) 90, 90, 90 Average B-factor (Å2)  
Wavelength (Å) 1.5418 Main chains 44.2 
Resolution range (Å)* 29.6-2.69 (2.74-2.69) Side chains 46.7 
Unique reflections 82043 Water molecules 34.0 
Completeness (%)* 99.9 (99.9) FAD molecules 46.3 
Multiplicity* 7.4 (7.3) R.M.S Deviations  
Rmerge *# 0.215 (1.444) Bond Length (Å) 0.004 
Rpim*^ 0.084 (0.565) Bond Angles (°) 0.886 
Mean <I/σ(I)>* 10.5 (1.7) Ramachandran plot regions (%) 
CC1/2*† 0.993 (0.551) Favored 94.1 
solvent content (%, v/v) 45.7 Allowed 4.56 
Molecules per 
asymmetric unit 20 
Outliers 1.35 
 
FAD was observed to bind within the cofactor-binding site, at either side of the dimer 
interface similar to other FDOR-Bs (Figure 2.2A). Serine and threonine residues from 
the secondary chain of the dimer stabilize the adenosine (Figure 2.2C), suggesting that 
dimerization is necessary for cofactor binding similar to FMN and F420 dependent 
FDOR-Bs (Mashalidis et al. 2015; Kitamura et al. 2007). However, there is no apparent 
substrate-binding site on the Re-face of FAD in MSMEG_5243, which instead has an 
overlapping loop and β-sheets from the secondary chain closing over the cofactor 
(Figure 2.2A and 2.2B). The lack of any obvious small molecule substrate binding 
pocket is similar to structures of electron transfer proteins like flavodoxins (Crain & 
Broderick 2013; Hsieh et al. 2013), suggesting that MSMEG_5243 could be involved in 
protein-protein electron transfer instead of acting on a substrate like the other 
characterised FDORs.  
Figure 3.2. A. Dimeric structure of MSMEG_5243 with FAD bound at the dimer 
interface of both chains. Electron density represents the Fo-Fc omit map contoured at  
3 σ. B. Solvent accessible surface of MSMEG_5243 showing the buried flavin moiety. 
C. Residues involved in FAD binding. 
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3.4 Implications, key findings and future directions 
The work presented in this chapter highlight that the FDOR superfamily needs to be 
expanded to include the related FMN, FAD and heme binding proteins as well as the 
F420 binding proteins. All FDORs have the same core split β-barrel fold with different 
key residues that can identify their cofactor specificity, but have extremely varied 
substrate binding regions that specialise them for different functional roles. Overall, the 
FDORs appear to have undergone massive functional diversification and the ability to 
identify their cofactor preference is the first step in characterising their function.  
The identification of smaller sub-groups within the larger FDOR-A, FDOR-AA and 
FDOR-B groups simplifies the process of identifying the functional roles of these 
proteins in mycobacteria. For instance, the FDOR-A1 proteins are quinone reductases 
that can also promiscuously reduce aflatoxins and 4-nitroimidazoles, FDOR-AA1 
proteins can reduce lipids, FDOR-B3/B4 proteins are biliverdin reductases, FDOR-B7 
proteins are heme oxygenases and FDOR-B8 proteins are involved in the mycobacterial 
hypoxia response. As mentioned in the manuscript (Ahmed et al. 2015), reduction of 
quinones, lipids and biliverdin can be linked to the ability of mycobacteria to survive 
under adverse conditions and MSMEG_5243 could be involved in the response to 
hypoxia which triggers the persistent dormant state.  
Each of these sub-groups needs substantial further characterisation for their requirement 
in vivo and their role in mycobacterial pathogenesis, and the work presented in this 
chapter serves as a starting point of these analyses for future work. Currently available 
genome-wide mutagenesis studies in M. tuberculosis have shown that the FDORs are 
non-essential for growth in vitro (Sassetti et al. 2003; Griffin et al. 2011), and only one 
FDOR, Rv3369, is essential for survival in macrophages (Rengarajan et al. 2005). 
However, the role of these proteins in infection, immune evasion and latency remains to 
be investigated, with a particular interest in those that utilise F420, which has been 
shown to enhance mycobacterial tolerance to oxidative and nitrosative stress and is 
required for reactivation from latency (Purwantini & Mukhopadhyay 2009; Hasan et al. 
2010; Gurumurthy et al. 2013). 
Most of the mycobacterial FDORs characterised in this chapter are also conserved in 
other Actinobacteria and in Archaea, implying similar functional roles and substrate 
specificities. Several of the FAD and FMN binding FDORs groups are also abundant in 
other bacteria like Proteobacteria, and their functional importance remains unknown 
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despite several of them being structurally characterised and analysed for cofactor 
specificity (Hilario et al. 2012; Kitamura et al. 2007). Of particular interest was the 
identification of FDORs that belong to the F420 binding subgroups from Proteobacteria 
and Chloroflexi, even though they are not known to produce F420 (Greening, Ahmed et 
al. 2016). Hence the work presented in this chapter also forms a basis for the 
identification of the roles of these proteins in other bacteria and Archaea. 
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4.1 Introduction 
Out of the currently characterised flavin/deazaflavin oxidoreductases (FDOR), the 
FDOR-A1 sub-group presents the most urgent need for study due to their involvement 
in the activation of bicyclic 4-nitroimidazole prodrugs used against Mycobacterium 
tuberculosis (Singh et al. 2008; Cellitti et al. 2012). In the bacteria, these proteins are 
thought to be quinone reductases that confer resistance to oxidative stress (Gurumurthy 
et al. 2013), and they are also able to degrade carcinogenic aflatoxins and other 
coumarin derivatives (Taylor et al. 2010; Lapalikar et al. 2012a).  
Of particular interest is the mechanism of prodrug activation by Rv3547 in M. 
tuberculosis, which is also known as the deazaflavin dependent nitroreductase (Ddn). 
Based on the structure of this protein solved in complex with F420, it is thought that the 
reaction takes place on the Re- face of the cofactor, where the nitro- head is held in 
place by hydrogen bonds with surrounding tyrosine residues and the imidazole ring 
aromatically interacts with F420 (Cellitti et al. 2012). This  allows hydride transfer to 
take place, releasing toxic nitrous oxide that causes respiratory poisoning (Singh et al. 
2008; Manjunatha et al. 2009).  
Currently, the 4-nitroimidazole compounds delamanid (formally OCP-67683), 
pretomanid (formally known as PA-824) and TBA-354 are in use. Delamanid has been 
approved for use against multi-drug resistant infections and pretomanid and TBA-354 
are in phase III and phase II clinical trials respectively (Blair & Scott 2015; Tasneen et 
al. 2015). However, resistance to delamanid has already been reported in multi- and 
totally- drug resistant strains (Bloemberg et al. 2015), necessitating the improvement of 
the currently available compounds and generation of alternatives. This requires a 
detailed understanding of the reduction and activation mechanism of these compounds 
by the FDOR-A1 proteins, which can then aid in the rational drug-design process. 
The 4-nitroimidazole reduction is thought to require two steps, hydride transfer from the 
F420H2 molecule bound to the enzyme and the acquisition of a proton that can be 
donated by either F420H2 itself or the surrounding environment (Singh et al. 2008). The 
purpose of the work presented in this chapter is to elucidate whether the proton donor 
for the reaction can be F420H2 itself and to identify the correct starting point of the 
reaction (with protonated or deprotonated F420H2) for further computational studies on 
the detailed mechanism of this reaction.  
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4.2 Published article 
Protonation state of F420H2 in the prodrug-activating deazaflavin dependent 
nitroreductase (Ddn) from Mycobacterium tuberculosis 
A. Elaaf Mohamed, F. Hafna Ahmed, Sundaram Arulmozhiraja, Ching Y. Lin,  
Matthew C. Taylor, Elmars R. Krausz, Colin J. Jackson and Michelle L. Coote 
Molecular Biosystems 2016, 12: 1110-1113   
 
 
 
This paper was peer-reviewed and published as an original research article. Elaaf 
Mohamed performed the bulk of the work, including the computational spectra 
simulations, F420 purification and the spectroscopy experiments. I purified the proteins 
he used, helped develop the method to obtain the enzyme bound spectra, did the in 
silico substrate docking and corresponding figure, and wrote the experimental methods 
in the supplementary information. Sundaram Arulmozhiraja started and performed the 
early computational work and Ching Lin helped develop the computational methods. 
Elaaf’s supervisors Elmars Krausz, Colin Jackson and Michelle Coote helped him 
analyse the data and write the manuscript. 
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4.3 Implications, key findings and future directions 
This work shows that F420H2 is most likely to be in the deprotonated state when bound 
to the FDOR-A1 proteins. This has direct implications for the catalytic mechanisms of 
these enzymes, suggesting that the protonation step required to complete the reaction 
needs an alternative proton source that is not the cofactor itself. The most likely 
candidates are a water molecule from the surrounding environment or a residue in the 
enzyme active site, for instance one of the three tyrosine residues located at the active 
site of rv3547/Ddn (Cellitti et al. 2012; Ahmed et al. 2015). The requirement for an 
ideally located residue for proton donation may be part of the reason why some FDOR-
A1 proteins are able to reduce the 4-nitroimizadole prodrugs while the others cannot 
(Ahmed et al. 2015), although more work is required to confirm this hypothesis.   
This is the first study of its kind on a deazaflavin cofactor, and the question of whether 
F420H2 is stabilised in a deprotonated state in other F420H2-dependent enzymes is 
interesting. It is highly likely that the other FDORs also stabilise F420H2 in its 
deprotonated state, considering the similarity of the core protein fold that binds the 
cofactor and the conservation of the mode of F420 stabilisation where hydrogen bonding 
interaction patterns to the isoalloxazine rings remain conserved (Cellitti et al. 2012; 
Mashalidis et al. 2015; Ahmed et al. 2015). In addition, our work demonstrates that this 
finding is also reproducible for a different FDOR-A1 protein MSMEG_2027 (Mohamed 
et al. 2016). However, more investigation in required on the F420H2-dependent proteins 
belonging to other protein families like the archaeal F420H2-dependent methylene-
H4MPT reductase and F420H2-dependent NADP reductase (Warkentin et al. 2001; Ceh 
et al. 2009). These proteins could stabilise the cofactor differently as they have different 
protein folds and F420 binding modes, where the cofactor is stabilised for hydride 
transfer on its Si-face instead of the Re-face presented in the FDORs (Warkentin et al. 
2001; Ceh et al. 2009). 
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5.1 Introduction 
The discovery of the F420H2-dependent biliverdin reductases (F-BVR) presented in 
Chapter 3 (Ahmed et al. 2015) is a significant stepping stone in identifying the 
functional roles of F420 and the flavin/deazaflavin oxidoreductases (FDORs) in 
mycobacteria. These enzymes reduce the heme degradation product biliverdin to 
bilirubin which is a potent antioxidant capable of quenching reactive oxygen and 
nitrogen species (Stocker et al. 1987; Kaur et al. 2003).  
Recent work on pathogenic mycobacteria have highlighted that bilirubin and biliverdin 
can protect the infecting bacteria and increase their survival inside macrophages during 
early infection (Abdalla et al. 2015). Hence it is likely that the F-BVRs play some role 
in this protective mechanism (Ahmed et al. 2015), especially since the production of 
F420 has been shown to be important for protecting mycobacteria against oxidative and 
nitrosative stress (Purwantini & Mukhopadhyay 2009; Hasan et al. 2010; Gurumurthy et 
al. 2013). 
The F-BVRs are the first identified family of bacterial biliverdin reductases that are 
distinct from the mammalian proteins (Ahmed et al. 2015). Hence this chapter focuses 
on looking at its distribution and the characterisation of its reaction product and 
catalytic mechanism. This uses the structure of Rv2074 from Mycobacterium 
tuberculosis solved in complex with F420 along with mutagenesis studies and molecular 
dynamics simulations to propose a plausible substrate binding mode and reaction 
mechanism for this enzyme family. 
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5.2 Published article 
Rv2074 is a novel F420H2-dependent biliverdin reductase in Mycobacterium 
tuberculosis 
F. Hafna Ahmed, A. Elaaf. Mohamed, Paul D. Carr, Karmen Condic-Jurkic,  
Megan L. O’Mara and Colin J. Jackson 
Protein Science 2016, 25(9): 1692–1709. 
 
 
This paper has been peer-reviewed and published as an original research article in 
Protein Science. I performed all experiments unless otherwise stated, including the 
protein purification, enzyme activity assays, crystallography, in-silico substrate docking 
and bioinformatic analysis. Elaaf Mohamed proposed the reaction mechanism, edited 
the manuscript, and performed and analysed the molecular dynamics simulations with 
the help of Karmen Condic-Jurkic and Megan O’Mara. Paul Carr collected the 
crystallography data and finalised the structural refinement and Brendon Lee purified 
the F420 used. My supervisor Colin Jackson developed the project concept with me and 
helped me write the paper. Special thanks to Dr. Ruhu Qi’s in-house mutagenesis 
service that generated the Rv2074 mutants used in this work. 
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5.3 Implications, key findings and future directions 
Of the two FDORs in M. tuberculosis that are capable of reducing biliverdin, Rv2074 
seems to be the primary F-BVR and Rv1155 appears to only be promiscuously active 
with this substrate. Similar functional promiscuity and overlap have been observed for 
the FDOR-As and probably arises due to the common evolutionary origin of these 
proteins (Lapalikar et al. 2012a; Ahmed et al. 2015). 
F420 bound to Rv2074 is primarily stabilised by the deazaflavin, ribityl and 
phospholactyl groups. On the other hand, the oligo-glutamate chain is highly flexible 
even though it does associate with a binding groove lined with positively charged 
residues. This is consistent with the ability of FDORs to function with the mixture of 
F420 species with varying oligo-glutamate chain lengths that are produced in vivo 
(Greening, Ahmed et al. 2016).  
The F-BVRs are exclusive to Actinobacteria and are mostly conserved in pathogenic 
and commensal mycobacteria. The catalytic mechanism of these proteins relies on the 
stabilisation of the pyrrole groups of biliverdin that flank the reducing double bond. 
This is achieved by hydrogen bonding of its propionate chains and cation-π interaction 
of pyrrole group C (specified in the manuscript) with highly conserved arginine residues 
in the active site. The terminal pyrrole groups A and D remain flexible in the large 
solvent exposed binding site, suggesting the possibility of reducing other related 
compounds modified in these regions like mycobilins produced by mycobacterial heme 
oxygenases (Nambu et al. 2013). Further work is required to study the substrate 
specificity of these proteins. 
The reaction mechanism of the F-BVRs is likely to be similar to what has been 
proposed for the mammalian biliverdin reductases (Smith et al. 2008; Fu et al. 2012). 
The protonation of a pyrrole nitrogen creates a cationic intermediate that can undergo 
hydride transfer with F420H2, where the proton donor is most likely water or a 
hydroxonium ion generated and stabilised by a nearby arginine residue. This 
requirement for an alternate proton source is consistent with F420H2 being stabilised in 
its deprotonated state when bound to FDORs as presented in Chapter 4 (Mohamed et al. 
2016). 
F-BVRs reduce biliverdin-IXα to bilirubin-IXα. Biliverdin-IXα is the primary isomer 
produced by macrophages (Maines 1988), and its production is upregulated in 
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mycobacteria infected cells (Abdalla et al. 2015; Kumar et al. 2008; Shiloh et al. 2008; 
Silva-Gomes et al. 2013). Since the F-BVRs are secreted outside the bacteria (Målen et 
al. 2007) and bilirubin is an antioxidant (Kaur et al. 2003), the physiological relevance 
of these proteins in protecting mycobacteria against oxidative stress remains to be 
investigated. 
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6.1 Introduction 
The production of F420 as a redox cofactor has only been confirmed from Archaea and 
Actinobacteria (Greening, Ahmed et al. 2016). However, the taxonomic distribution of flavin 
deazaflavin oxidoreductases (FDORs) highlighted in Chapter 3 suggests the presence of F420-
dependent FDORs in Chloroflexi and Proteobacteria, although these organisms have not been 
experimentally shown to produce F420.  
The pathway for F420 production is complex and outlined in detail in Chapter 2 (Greening, 
Ahmed et al. 2016). It essentially involves the production of Fo (5-deaza-7,8-didemethyl-8-
hydroxy-5-deazariboflavin) from a precursor of riboflavin synthesis by two enzymes called 
CofG and CofH in Archaea (Graham & Xu 2003) that are fused into one protein CofG-CofH 
called FbiC in Actinobacteria (Choi et al. 2002). The phospho-lactyl group is then transferred 
to Fo to form F420-0 by CofD in Archaea which is known as FbiA in Actinobacteria (Graupner 
et al. 2002). This group originates from L-lactyl-2-diphospho-5'-guanosine produced by CofC 
from precursors from the lactate biosynthesis pathway (Graupner & White 2001; Grochowski 
et al. 2008). Finally, the polyglutamate tail is added to F420-0 by CofE in Archaea (Li et al. 
2003) which is known as FbiB in Actinobacteria (Choi et al. 2001). 
This chapter presents a comparative genomic study aimed at identifying F420 producing 
organisms by showing the taxonomic distribution of the key enzymes in the F420 biosynthesis 
pathway CofG, CofH, CofC, CofD and CofE. Phylogenetic analysis was also used to shed 
light on the evolution of F420 production. 
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6.2 Published article 
The methanogenic redox cofactor F420 is widely synthesized by aerobic soil bacteria 
Blair Ney*, F. Hafna Ahmed*, Carlo R. Carere, Ambarish Biswas, Andrew C. Warden, 
Sergio E. Morales, Gunjan Pandey, Stephen J. Watt, John G. Oakeshott,  
Matthew C. Taylor, Matthew B. Stott, Colin J. Jackson and Chris Greening 
*BN and FHA contributed equally to this work 
The ISME Journal 2016, doi:10.1038/ismej.2016.100. 
 
 
 
 
This paper has been peer-reviewed and published as an original article in the International 
Society for Microbial Ecology Journal. I performed the sequence retrieval and curation, 
phylogenetic and coevolution analysis, homology modelling and contributed to writing up 
these sections. Blair Ney retrieved the genomic organisation data and performed the 
experimental work in confirming F420 production with the help of Stephen Watt for the mass 
spectrometry analysis. Carlo Carere and Ambirash Biswas performed the metagenomic 
analysis. Andrew Warden, Sergio Morales, Gunjan Pandey, John Oakeshott and Matthew 
Taylor edited the manuscript and supervised students. Colin Jackson and Chris Greeing 
helped Blair and me with data analysis, co-wrote the manuscript and designed the study with 
Gunjan Pandey and John Oakeshott.  
The supplementary material files for the large data tables S1 and S2 are not presented in this 
thesis and are available from the publisher.  
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Supporting Information 
Figure S1. Homology models (light grey) showing conserved protein folds and F420 
binding residues (cyan, labelled) in predicted F420-dependent oxidoreductases 
encoded in the genomes of Paracoccus denitrificans, Oligotropha carboxidovorans, 
and Thermomicrobium roseum. These are overlaid with the structures of the closest 
related proteins (dark grey) solved in complex with F420 (yellow), where conserved 
residues involved in F420 binding are shown as sticks. (A) and (B) Predicted F420-
reducing NADPH reductases (Fno) from P. denitrificans (accession: 
WP_011747447.1) and O. carboxidovorans (accession: WP_012562166.1), 
respectively, modelled using the characterised Fno (PDB ID: 1JAY) from 
Archaeoglobus fulgidus. (C) Predicted F420-reducing glucose 6-phosphate 
dehydrogenase (Fgd) from T. roseum (accession: WP_012643298.1) modelled using 
the characterized Fgd from Mycobacterium tuberculosis (PDB ID: 3B4Y). (D) 
Predicted flavin/deazaflavin dependent oxidoreductase (FDOR) superfamily sub-
group A from T. roseum (accession: WP_015922093.1) modelled using the structure 
of an FDOR-A from Nocardia farcinica (PDB ID: 3R5Z). (E) Structure of the FDOR 
subgroup B protein from T. roseum (accession: WP_012642380.1) modelled using 
the structure of an FDOR-B from Myocbacterium tuberculosis (PDB ID: 4QVB). (F) 
to (I) Sequence alignments of the predicted proteins used for homology modelling 
and their structurally characterised homologs, highlighting the conserved F420 binding 
regions in cyan. Conserved residues include the hydrophobic and polar residues for 
isoalloxazine stabilization, and positively charged side-chains and amide groups 
from the protein backbone positioned to interact with the oligo-glutamate chain.  
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Figure S2. Sequence similarity networks of the F420 biosynthesis enzymes. The 
diversity and distribution of the protein sequences encoding five specific enzymes 
required for F420 biosynthesis (CofC, CofD, CofE, CofG, CofH) is shown. In this 
analysis, the nodes represent individual protein sequences (colored by taxon) and 
the edges represent the all-vs-all BLAST E-values between them at the specified 
logE cut-offs. 
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Figure S3. Co-evolution of the F420 maturases. The topology of the phylogenetic 
trees of the five proteins specifically required for F420 biosynthesis (CofG, CofH, 
CofC, CofD, CofE) were compared. Axes represent interspecies distances and 
numbers in the right hand corner are Pearson’s correlation coefficients.  
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Figure S4. Phylogenetic trees of the CofG and CofH proteins including 
sequences from Cyanobacteria omitted from the analysis shown in Figure 4A. 
 
 
 
 
Table S1 (xlsx). List of F420 biosynthesis enzymes. The protein sequences of all 
five enzymes specifically required for F420 biosynthesis (CofG, CofH, CofC, 
CofD, CofE) are listed.  
 
 
Table S2 (xlsx). List of bacteria and archaea encoding all five enzymes 
specifically required for F420 biosynthesis (CofG, CofH, CofC, CofD, CofE). 
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Table S3 (xlsx). Taxonomic distribution of the five enzymes specifically 
required for F420 biosynthesis (CofG, CofH, CofC, CofD, CofE). 
Phylum Class CofGH CofG CofH CofC CofD CofE Product 
 
        
Bacteria 
        
Actinobacteria Actinobacteria 760 21 28 868 869 932 F420, Fo 
 Acidimicrobiia 4   3 5 5 F420, Fo 
 Nitriliruptoria 1    1 1 F420, Fo 
 Rubrobacteria 1   3 3 3 F420, Fo 
 Thermoleophilia 6   8 7 8 F420, Fo 
Chloroflexi Ktedonobacteria 2   3 2 2 F420, Fo 
 Thermomicrobia 2 3 3 4 5 5 F420, Fo 
 Ardenticatenia  1 1 1 1 1 F420, Fo 
 Anaerolineae    2 2 2 ? 
 Chloroflexia    7 7 8 ? 
 Caldilineae     1 1 - 
Proteobacteria Alphaproteobacteria 70 16 16 78 84 92 F420, Fo 
 Betaproteobacteria 9 4 5 18 15 19 F420, Fo 
 Gammaproteobacteria 5 15 14 18 22 25 F420, Fo 
 Deltaproteobacteria  1 1 1 2  Fo 
Firmicutes Bacilli  2 3 1 1 1 F420, Fo 
 Clostridia  1 1 1 1 2 F420, Fo 
Tectomicrobia   2 1 2 2 2 F420, Fo 
Cyanobacteria  1 112 118   1 Fo 
Acidobacteria   1     - 
 
        
Archaea 
        
Euryarchaeota Archaeoglobi  7 7 7 7 7 F420, Fo 
 Halobacteria  103 104 108 101 104 F420, Fo 
 Methanobacteria  18 26 17 13 17 F420, Fo 
 Methanococci  14 15 13 14 14 F420, Fo 
 Methanomicrobia  45 77 48 44 48 F420, Fo 
 Methanopyri  1 1 1 1 1 F420, Fo 
Aigarchaeota      3 4 ? 
Bathyarchaeota     1 2 5 ? 
Geoarchaeota   1 1 1 1 1 F420 
Lokiarchaeota      1 1 ? 
Thaumarchaeota   12 11 14 12 12 F420 
         
Eukarya         
Chlorophyta Chlorophyceae 1      Fo 
 Trebouxiophyceae 3      Fo 
 Mamiellophyceae 4      Fo 
Rhodophyta Cyanidiophyceae  1 1    Fo 
Streptophyta Bryopsida 2      Fo 
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Table S4. Distribution of known F420-dependent oxidoreductases in the six 
phyla where F420 is predicted to have a major role. Cells are shaded according 
to whether these proteins are present in all (dark blue), most (mid to dark blue), 
some (mid to light blue), few (light blue), or none (gray) of their sequenced 
species. 
 
                                                            Chapter 6 – Abundance and distribution of F420 producing organisms 
162 
 
Table S5 (xlsx). Information on the 19 metagenomes sampled, and distribution 
of the matched BLAST hits by enzyme and taxon.  
 
 
 
 
 
 
 
 
 
 
 
Sample CofGH CofG CofH CofC CofD CofE Total 
reads 
Average 
Fo 
reads 
Average 
F420 
reads 
Ratio 
Fo/F420 
Agricultural soil 1 246 25 47 119 113 132 682 159 136.4 1.17 
Agricultural soil 2 420 23 43 157 191 161 995 243 199 1.22 
Bog forest soil 1 222 31 38 103 94 98 586 145.5 117.2 1.24 
Bog forest soil 2 155 36 29 119 109 91 539 110 107.8 1.02 
Coastal 
upwelling 1 
242 50 59 45 70 87 553 175.5 110.6 1.59 
Coastal 
upwelling 2 
185 39 56 38 79 73 470 140 94 1.49 
Deep ocean 1 169 117 130 54 108 111 689 208 137.8 1.51 
Deep ocean 2 168 116 100 33 63 90 570 192 114 1.68 
Forest soil 1 369 48 58 107 133 166 881 237.5 176.2 1.35 
Forest soil 2 387 61 80 107 142 168 945 264 189 1.40 
Great lakes 1 182 9 8 22 25 41 287 99.5 57.4 1.73 
Great lakes 2 216 18 7 32 53 59 385 120.5 77 1.56 
Hot springs 1 40 5 28 76 51 50 250 36.5 50 0.73 
Hot springs 2 19 5 31 59 48 61 223 27.5 44.6 0.62 
Human gut 0 0 2 1 0 0 3 1 0.6 1.67 
Marine sediment 1 12 31 25 42 61 172 22 34.4 0.64 
Permafrost soil 1 129 21 37 106 121 97 511 93.5 102.2 0.91 
Permafrost soil 2 85 9 39 85 73 81 372 66.5 74.4 0.89 
Termite gut 0 0 0 2 0 0 2 0 0.4 0.00 
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Table S6. List of accession numbers of F420-dependent oxidoreductases 
predicted to be encoded in the genomes of Paracoccus denitrificans, 
Oligotropha carboxidovorans, and Thermomicrobium roseum.  
F420-dependent 
oxidoreductase 
Paracoccus 
denitrificans 
Oligotropha 
carboxidovorans 
Thermomicrobium 
roseum 
Fno: F420-reducing NADPH 
dehydrogenase 
WP_011747447.1 WP_012562166.1 - 
Fgd: F420-reducing glucose 
6-phosphate 
dehydrogenase 
- - WP_012643298.1 
LLHTs: Hypothetical F420H2-
dependent luciferase-like 
hydride transferases  
WP_011751231.1 
WP_011747448.1 
WP_011746550.1 
WP_011747178.1 
WP_012562164.1 
WP_012564565.1 
WP_015922389.1 
WP_052294071.1 
WP_012641819.1 
WP_012641867.1 
WP_052294016.1 
WP_015922493.1 
WP_015922304.1 
FDOR-As: Hypothetical 
F420H2-dependent 
flavin/deazaflavin 
oxidoreductases  
- - WP_015922093.1  
FDOR-Bs: Hypothetical 
F420H2-dependent 
flavin/deazaflavin 
oxidoreductases 
  
WP_012643102.1 
WP_012642380.1 
WP_012642831.1 
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6.3 Implications, key findings and future directions 
This chapter highlighted that the F420 biosynthesis pathway is not just conserved in 
Archaea and Actinobacteria, but is also present in multiple species of Chloroflexi and 
Proteobacteria. This is consistent with the presence of F420-dependent FDORs in these 
organisms (Ahmed et al. 2015), and whether these are functionally homologous to the 
mycobacterial proteins remains to be investigated. The pathway is also present in some 
Firmicutes, Tectomicrobia and Archaea other than Euryarchaeota and is conserved in 
pathogenic mycobacteria though it is notably absent in pathogenic Proteobacteria. 
Metagenomic analysis showed that F420 production is predominant in soil and sediment 
dwelling bacteria, and not very abundant in gut bacteria. Most of Actinobacteria, 
Chloroflexi and Proteobacteria identified to encode the F420 biosynthesis proteins are 
also soil dwelling aerobes or facultative anaerobes, although the role of this cofactor in 
soil bacteria remains to be fully investigated.  
This work also sheds light on the evolution of F420 biosynthesis. While the production of 
Fo seems to have first evolved in Archaea, the synthesis of the L-lactyl-γ-L-glutamyl-L-
glutamic acid tail appears to have originated in a bacteria, most probably an ancestral 
Actinobacteria. This is consistent with recent analysis showing that CofC, CofD and 
CofE are likely to have been acquired by Archaea from horizontal gene transfer from 
bacteria (Nelson-Sathi et al. 2015). Other bacteria like Chloroflexi, Proteobacteria, 
Firmicutes and Tectomicrobia most likely acquired these enzymes through horizontal 
gene transfer, and hence are present only sporadically among these organisms. These 
proteins co-evolved, suggesting selection for F420 production rather than the production 
of its precursor Fo.  
The evolution of the complex pathway for F420 production from Fo in an actinobacterial 
ancestor suggests that this cofactor provided a significant selective advantage to these 
organisms. However, at least in mycobateria, F420 production is not essential for 
viability even though it increases survival in oxidative stress and in recovering after 
dormancy (Purwantini & Mukhopadhyay 2009; Hasan et al. 2010; Gurumurthy et al. 
2013). Currently, the only known protein families to utilise this cofactor in 
Actinobacteria are the FDORs and the luciferase-like hydride transferases (LLHTs), 
although it is possible that more families remain to be discovered. A better 
understanding of the roles of these proteins will highlight the significance of F420 in 
these organisms, including pathogenic mycobacterial species and soil bacteria. 
                                                                                                                        Chapter 7 – General discussion 
165 
 
 
 
 
 
 
Chapter 7 –  
General Discussion
                                                                                                                        Chapter 7 – General discussion 
166 
 
7.1 Overview 
The work presented in this thesis highlights the diversity of the flavin/deazaflavin 
oxidoreductases (FDORs), particularly in mycobacteria. Although these proteins were 
initially discovered as a group of F420H2-dependent reductases with overlapping 
functions (Taylor et al. 2010; Lapalikar et al. 2012a), this family needs to be expanded 
to include the related proteins with other cofactor specificities (FMN, FAD and heme) 
as well.  
The five FDOR structures presented, along with previously solved structures, have 
allowed the elucidation of the key residues involved in determining the cofactor 
specificity of these proteins. This forms the basis for identifying their catalytic 
functions, which along with in silico modelling, clues from their genomic context and 
sequence homology to related proteins, led to the discovery of the  F420H2-dependent 
biliverdin reductases (F-BVRs), F420H2-dependent fatty acid saturases, heme 
oxygenases and potential electron transport proteins among the mycobacterial FDORs. 
In particular, the F-BVRs are the only known bacterial family of biliverdin reductases 
that are not homologous to the mammalian proteins of the same function. All these 
functions have implications in mycobacterial persistence and pathogenesis, and their 
discovery forms the basis for further work in elucidating the role of FDORs in vivo and 
their catalytic mechanisms. The observed functional diversity in this protein 
superfamily is possible due to the versatility of the structure of the substrate binding 
pocket despite a common split β-barrel fold for cofactor binding. In addition, the 
production of F420 in organisms beyond Actinobacteria and Archaea and the presence of 
FDORs in these organisms suggest that the FDOR superfamily is also important in 
bacteria other than mycobacteria, performing roles that remain to be discovered.  
7.2 FDORs in mycobacterial persistence and pathogenesis 
The FDORs seem to have evolved for functional roles that adapt mycobacteria to 
survive and persist in unfavourable environments. They are the largest characterised 
family in mycobacteria to utilise F420, the production of which is required for survival 
during oxidative and nitrosative stress and for resuscitation after dormancy (Purwantini 
& Mukhopadhyay 2009; Hasan et al. 2010; Gurumurthy et al. 2013). The importance of 
F420 for pathogenesis is implied by the work presented in Chapter 6 that shows the 
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conservation of its production pathway in pathogenic mycobacteria, even in 
Mycobacterium leprae, which has undergone massive genomic decay (Cole et al. 2001).   
Mycobacteria are notorious for their ability to go into a metabolically dormant latent 
state and then reactivate again when conditions are more favourable (Gengenbacher & 
Kaufmann 2012). Dormancy triggers include hypoxia (low oxygen) and oxidative stress 
which initiates the production of the transcription factor DosR (Chaves et al. 2015). 
DosR controls the expression of ~50 genes belonging to the DosR regulon that adapt the 
bacterial physiology for low metabolic activity and reduced proliferation (Boon & Dick 
2002; Park et al. 2003). Recently, it was shown that the FDOR MSMEG_5243 is 
expressed in the same operon as DosR in Mycobacterium smegmatis (Berney et al. 
2014) and is highly upregulated during hypoxia (Berney & Cook 2010). This protein 
binds FAD with a high affinity (Chapter 3, Ahmed et al. 2015), and the conservation of 
its genomic context in pathogenic mycobacteria and structural characterisation 
presented in Chapter 3 is the first step towards identifying its contribution to the 
mycobacterial hypoxia response.  
During latency, M. tuberculosis accumulates host lipids that serve as an energy source 
for growth and persistence (Daniel et al. 2011). Fatty acid modification is also important 
to maintain the cell wall integrity (Yuan et al. 1998) and for host-cell interactions 
required for virulence (Schué et al. 2010; McGarvey & Bermudez 2001; Forrellad et al. 
2013). Chapter 3 (Ahmed et al. 2015) demonstrated the ability of an FDOR-AA to 
reduce arachidonic acid, their general high affinity for this lipid and their probable 
localisation to the cell membrane where most lipid modification takes place (Crellin et 
al. 2013). These findings strongly imply a role of the FDOR-AAs in modifying fatty 
acids and related substrates. However, more work is required to elucidate the exact fatty 
acid substrates of these enzymes. 
The proposed physiological role of the FDOR-A1 proteins described in Chapter 3 is 
reducing menaquinone to menaquinol in mycobacteria (Gurumurthy et al. 2013), which 
also has implications for mycobacterial pathogenesis. Increased menaquinol production 
has been shown to be important to reactivate dormant M. tuberculosis (Hartman et al. 
2014), as it serves as an electron source to the respiratory chain that generates the proton 
motive force required for ATP production (Cook et al. 2014). Whether the FDOR-A1 
proteins have any direct involvement with this process remains to be investigated. 
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Finally, the F-BVRs described in Chapter 3 and Chapter 5 reduce biliverdin to bilirubin, 
which is a strong anti-oxidant against nitric oxide produced by macrophages as an 
immune response (Kaur et al. 2003; Chan et al. 1992). Chapter 5 (Ahmed et al. 2016) 
showed that F-BVRs are able to reduce the most abundant biliverdin isomer (IXα) 
produced by human macrophages upon mycobacterial infection (Maines 1988; Abdalla 
et al. 2015). This, along with the likely secretion or localisation of these proteins to the 
mycobacterial cell wall (Målen et al. 2007; Målen et al. 2010; De Souza et al. 2011), 
suggests that they could reduce biliverdin produced by the host cell, forming an anti-
oxidative pocket around the invading bacteria. Indeed, increased biliverdin and bilirubin 
concentrations have been shown to have a protective effect on invading mycobacteria 
during early infection (Abdalla et al. 2015). This hypothesis remains to be confirmed by 
in vivo experimental work. 
7.3 Catalytic mechanisms of F420H2-dependent FDORs 
The F-BVRs described in Chapter 3 and Chapter 5 are the only known family of 
biliverdin reductases that are distinct from the mammalian proteins of the same 
function. The detailed analysis of the F420 bound structure of the M. tuberculosis F-BVR 
Rv2074 and its substrate binding mode presented in Chapter 5 (Ahmed et al. 2016) has 
provided insight into the catalytic mechanism of F420H2 dependent reductases in the 
FDOR superfamily. The overall reaction appears to proceed similarly to the 
nicotinamide dependent reaction of the mammalian proteins (Smith et al. 2008; Fu et al. 
2012), where protonation of biliverdin creates a cation intermediate that readily 
undergoes hydride transfer with F420H2. This inference is also consistent with F420H2 
being stabilised in the FDOR binding site in a deprotonated state as presented in 
Chapter 4, where an alternate proton source is required for the reaction to proceed 
(Mohamed et al. 2016). In the case of F-BVRs, this could be fulfilled by a hydroxonium 
ion generated and stabilised by nearby arginine residues as suggested for the human 
biliverdin reductases (Smith et al. 2008; Fu et al. 2012).  
The active site architecture of the F-BVRs can also be used to draw inferences for the 
pro-drug activating mechanism of the FDOR-A1 proteins presented in Chapter 3. The 
crystal structure of the FDOR-A1 protein MSMEG_2027 and the structures of its 
homologues highlight the presence of conserved tyrosine residues in the active site 
(Chapter 3, Ahmed et al. 2015). These residues are thought to stabilise the 4-
nitroimidazole prodrugs (Cellitti et al. 2012), although their exact requirement for 
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catalysis remains unknown. Comparison of the F420 bound structures of these proteins 
with the F-BVRs shows that one of these tyrosines required for catalysis (Cellitti et al. 
2012; Ahmed et al. 2015) is also structurally conserved in the F-BVRs (Chapter 5, 
Ahmed et al, 2016) and have a similar role of associating with a carbonyl of the 
pyrimidine group of F420 for stabilisation. In addition, the deprotonated state of F420H2 
bound to FDOR-A1 proteins presented in Chapter 4 (Mohamed et al. 2016) implies that 
the surrounding tyrosine residues may serve as a proton source or otherwise stabilise a 
nearby water molecule or hydroxonium ion for proton donation similar to the arginine 
residues in the F-BVRs. Further work is required to elucidate the exact catalytic 
mechanism involved in pro-drug activation by the FDOR-A1 proteins, as well as in the 
reduction of other substrates of this FDOR subgroup like quinones and 
furanocoumarins. 
7.4 FDOR evolution 
The overall conservation of the split β-barrel fold in the FDORs presented in Chapter 3 
suggests a common evolutionary origin of these proteins (Ahmed et al. 2015). 
Specifically, this region is involved in cofactor binding, where the binding mode for the 
flavin cofactors remain conserved. The flavin or deazaflavin moieties are stabilised by 
hydrogen bonding to the pyridine nitrogen and carbonyl groups, the ribityl moiety is 
held by interactions to the hydroxyl groups and the phosphate group is stabilised by 
conserved tryptophan (in FDOR-As and FDOR-AAs) and lysine (in FDOR-Bs) 
residues. Also, the Re-faced binding mode of FMN and FAD in this protein family is 
conserved in the F420 binding proteins as an evolutionary remnant, even though all other 
characterised F420 binding proteins catalyse their reactions on the Si-face of the cofactor 
as shown in Chapter 2 (Greening, Ahmed et al. 2016).  
Currently, all functionally characterised F420 specific proteins in this family are 
reductases (Singh et al. 2008; Gurumurthy et al. 2013; Ahmed et al. 2015; Taylor et al. 
2010) while all FMN binding proteins are oxidases (Safo et al. 2000; Xu et al. 2013). 
Hence the nature of the cofactor seems to dictate the reaction catalysed by these 
enzymes, which was supported by the finding that the same FDORs behave as 
reductases with F420 and oxidases with FMN (Lapalikar, et al. 2012b). The evolution of 
cofactor specificity in these proteins could offer insight into how these proteins are 
specific for reductase or oxidase activities. The work presented in Chapter 6 (Ney, 
Ahmed et al. 2016) suggests that F420 is unlikely to have been produced in the last 
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universal common ancestor (LUCA), while Chapter 3 (Ahmed et al. 2015) shows that 
FDORs are present in all three kingdoms of life, consistent with their presence in the 
LUCA. Therefore it is more plausible that the FDORs initially evolved to utilise either 
of the ubiquitous flavin cofactors FMN or FAD and then adapted for F420 utilisation. In 
line with this, the multiple cofactor preferences found amongst the FDOR-Bs suggests 
that the ancestral FDORs resembled these, rather than the FDOR-As that appear to have 
specialised for F420 utilisation. Alternatively, proteins with the split β-barrel fold have 
also been discovered to utilise pyruvate as a cofactor (Leiros et al. 2004), suggesting 
that a similar small molecule could have served as a cofactor for ancestral FDORs. 
Despite similarities in cofactor binding, the substrate binding pocket of the FDORs is 
extremely robust to modification (Chapter 3, Ahmed et al. 2015). This is clearly 
demonstrated in the structures of the FAD and heme binding protein MSMEG_4975 
and the heme oxygenase MSMEG_6519 presented in Chapter 3. MSMEG_4975 has the 
substrate binding region modified to accommodate a heme molecule as a second 
cofactor, with expansion to include residues that bind the propionate side chains and to 
form hydrophobic interactions with the vinyl groups. In MSMEG_6519, an additional 
conserved domain is introduced to the C-terminus, although its role in the catalytic 
mechanism requires further investigation. Interestingly, its homologue from 
Helicobacter pylori has this region on the N-terminus of the protein instead of the C-
terminus, although it is still located near the catalytic site (Hu et al. 2011), further 
highlighting the flexibility of these proteins for active site modification. Such conserved 
domain addition for substrate binding and catalytic activity is also observed in the FMN 
dependent FDORs pyridoxamine-5’-phosphate oxidase (PnPOx) (Safo et al. 2000) and 
phenazine biosynthesis protein PhzG (Xu et al. 2013). 
In addition, the structural and functional analysis of the F420 binding FDORs presented 
in Chapter 3 and Chapter 5 also highlight the plasticity of their substrate binding 
pockets. The FDOR-As are functionally promiscuous, where the same proteins can bind 
and reduce quinones, furanocoumarins and 4-nitroimidazoles (Singh et al. 2008; Taylor 
et al. 2010; Gurumurthy et al. 2013). All FDOR-A1 proteins can degrade quinones with 
a high efficiency but only one homologue in M. tuberculosis (Ddn) can activate 4-
nitroimidazole prodrugs (Gurumurthy et al. 2013), suggesting that their probable 
physiological function can tolerate minor structural and sequence variation but requires 
more specific interactions to reduce exogenous compounds (Chapter 3, Ahmed et al. 
2015). The F-BVRs also demonstrate functional promiscuity; the active site of the 
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FDOR-B3 proteins (Rv1155) clearly does not allow optimal biliverdin binding, but 
these proteins are still able to proceed with the reaction at a reduced rate (Chapter 5, 
Ahmed et al. 2016). The active site structure of the FDOR-B4 Rv2074 is also large and 
open, with specific biliverdin-protein interactions only for the propionate side chains 
and pyrrole ring adjacent to the reducing double bond. This suggests the possibility for 
activity with other porphyrin substrates as well, for instance the biliverdin analogue 
mycobilin produced by mycobacterial heme oxygenases (Nambu et al. 2013) and corrin 
intermediates in the cobalamin (vitamin B12) biosynthesis pathway (Raux et al. 2000).  
7.5 F420 and FDORs in other bacteria 
Chapter 6 (Ney, Ahmed et al. 2016) highlighted that F420 production is spread much 
wider than previously thought, signifying physiological functions beyond mycobacterial 
persistence and archaeal methanogenesis as reviewed in Chapter 2 (Greening, Ahmed et 
al. 2016). In particular, the production of this cofactor is common in soil bacteria, 
although the reason behind this is not yet understood. It is known that FDOR-As are 
capable of degrading aflatoxins (Taylor et al. 2010; Lapalikar et al. 2012a) that are 
present as toxic contaminants in soil (Angle 1986; Accinelli et al. 2008). Heme 
oxygenases from the FDOR superfamily are present in soil mycobacteria, Chloroflexi 
and Proteobacteria (Chapter 3, Ahmed et al. 2015), and can contribute to iron 
acquisition from the environment which is critical for bacterial growth (Li & Stocker 
2009). The F-BVRs could also aid in the heme degradation process by further reduction 
of the biliverdin produced, although these enzymes are absent in Chloroflexi and 
Proteobacteria (Chapter 5, Ahmed et al 2016). In Actinobacteria, other FDOR-Bs are 
required for antibiotic production (Zhang et al. 2008; Wang et al. 2012) that can aid in 
bacterial survival by eliminating competitive species. 
It is possible that the wide substrate specificity and plasticity of the FDORs discussed in 
Section 7.4 is part of an adaptation mechanism of these bacteria to degrade toxic 
exogenous compounds, allowing soil remediation to increase bacterial survival. Apart 
from the FDORs, other F420 dependent proteins belonging to the luciferase-like hydride 
transferase (LLHT) superfamily also aid in the F420 dependent survival mechanisms in 
bacteria. They are involved  in the production of antibiotics (Greening, Ahmed et al. 
2016), degradation of the toxic compound malachite green that was used in aquaculture 
(Guerra-Lopez et al. 2007) and in the degradation of picrate and related explosives for 
use as a carbon and nitrogen source (Ebert et al. 2001).  
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7.6 Future directions  
This work forms a basis for studying the functional roles of F420 and FDORs in 
mycobacteria and other bacteria. A particular focus should be placed on confirming the 
physiological significance of the potential roles of FDORs in mycobacterial persistence 
discussed in Section 7.2, including the F420H2-dependent quinone reductases, F-BVRs 
and the FAD binding protein MSMEG_5243. The functional characterisation of the 
FDORs in mycobacteria is still far from complete, and requires the identification of 
substrates and confirmation of catalytic activity for the majority of the FDOR-AAs and 
FDOR-Bs. In addition, detailed mechanistic studies on the F420 dependent FDORs 
would aid in improved nitroimidazole pro-drug design, identifying the structural basis 
for resistance to currently used compounds and also in the engineering of these enzymes 
to exploit their broad substrate specificities observed in nature. Such enzyme 
engineering projects would also benefit from an understanding of the evolution of these 
proteins looking at how cofactor specificity dictates enzyme function. Lastly, the overall 
understanding of the significance of F420 in mycobacteria will be enhanced by a 
similarly detailed look at the LLHT protein superfamily that is also abundant and 
conserved in mycobacteria (Selengut & Haft 2010).  
7.6 Conclusions 
FDORs are extremely diverse in mycobacteria, and include functional roles as quinone 
reductases, lipid saturases, heme oxygenases and biliverdin reductases that can 
contribute to mycobacterial persistence and pathogenesis. These functions are 
determined by their cofactor specificities and structural characterisation shows flexible 
active sites that allow promiscuous activity with a wide variety of substrates in some 
FDORs. Detailed analysis of the catalytic mechanism of the F420 dependent biliverdin 
reductases suggest that it proceeds similar to the nicotinamide dependent reaction in the 
equivalent mammalian proteins. Finally, the abundance of F420 producing bacteria 
indicates physiological roles of the FDORs in these organisms in addition to their 
involvement in mycobacterial persistence. 
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Appendix I: General background on protein X-ray crystallography 
Detailed reviews on protein crystallisation, data collection and processing are provided 
in a number of textbooks and reviews including Rupp (2010), Hauptman (1991), Smyth 
& Martin (2000) and Rhodes (2006). What follows is a very brief overview of the 
theory behind the methods required for solving the structures presented in this thesis. 
Determining space groups 
The smallest repeatable unit (by simple translations) in a crystal lattice is defined by its 
unit cell with edge lengths a,b,c and internal angles α,β,γ. The observed x-ray 
diffraction pattern from the crystal is the Fourier transform of the real space crystal 
lattice, where diffraction spots occur in reciprocal space at positions indicated by their 
Miller’s indices (h,k,l). In real space, h,k,l defines crystallographic planes in the lattice 
and indicates the positions each plane intercepts the edges of the unit cell at fractions 
a/h, b/k and c/l. The intensities of the diffracted beams that identify which planes 
diffraction has occurred from and depend on the atomic composition of the crystal 
lattice, are also recorded in association with their Miller’s indices.  
The diffraction spots are only detected when Braggs Law (1) is satisfied.  
(1) 𝑛𝜆 = 2𝑑ℎ𝑘𝑙𝑠𝑖𝑛𝜃, 
where n = integer, λ = wavelength of the x-ray beam, d = distance between crystal 
lattice planes (h,k,l) that defines the position of the spot on the diffraction image and  
θ = the angle of reflection of the diffracted beam. 
The scattering angle (θ) that gives rise to the furthest spots from the detector origin 
(largest h,k,l) with reasonable completeness can be used to calculate the maximum 
resolution (d) of the dataset in angstrom (Å) using (1). 
The systematic absence of reflections along with the regular spacing between reflections 
in the diffraction pattern allows the prediction of the “space group” of the crystal lattice. 
This determines the symmetry operations required on the asymmetric unit to generates 
the full structure, which is the smallest repeatable structure or motif in the crystal that 
needs to be solved. Asymmetric units are packed into the unit cell, which is the smallest 
repeatable unit containing all the symmetry operations required to generate the whole 
crystal lattice by simple translations. The symmetry functions required on the 
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asymmetric unit to generate the unit cell and its contents are defined by the 65 possible 
space groups for proteins (limited in number by the stereo specificity of amino acids in 
nature), generated from the combination of the 14 Bravais lattices (belonging to 7 lattice 
systems) with the 32 crystallographic point groups. The symmetry operations of these 
space groups are presented and defined in the International Tables for Crystallography 
(2015) and are also built into the various computational platforms used for data 
processing including CCP4 (Collaborative Computational Project 1994) and PHENIX 
(Adams et al. 2010) used to solve and refine the structures presented in this thesis. 
Diffraction data to electron density 
The amplitude of the diffracted beam |Fhkl| is proportional to the square root of the 
intensities of the spots Ihkl on the diffraction pattern after accounting for various 
experimental parameters (3). 
(3) 𝐼ℎ𝑘𝑙 ∝ |𝐹ℎ𝑘𝑙|2 
Both the amplitude |Fhkl| and phase angle ϕ of the diffracted beam are required to 
calculate the observed structure factors Fhkl (4) that are related to the atomic coordinates 
in real space (x,y,z) by the structure factor equation (5). The Fourier transform of this 
equation can be used to calculate of the electron density of the atoms ρ(x,y,z) required to 
solve the structure and vice versa (6), which can also be written as (7) to show the 
requirement for the experimentally obtained amplitude |Fhkl| and phase ϕ. 
(4) 𝐹ℎ𝑘𝑙 =  𝑒𝑖𝜑ℎ𝑘𝑙|𝐹ℎ𝑘𝑙|, 
(5) 𝐹ℎ𝑘𝑙 =  ∑ 𝑓𝑗𝑛𝑗=1 𝑒2𝜋𝑖(ℎ𝑥𝑗+𝑘𝑦𝑗+𝑙𝑧𝑗), 
(6) 𝜌(𝑥, 𝑦, 𝑧) =  1
𝑉
∑ ∑ ∑ 𝐹ℎ𝑘𝑙𝑙𝑘ℎ 𝑒
−2𝜋𝑖(ℎ𝑥+𝑘𝑦+𝑙𝑧)
, 
(7) 𝜌(𝑥, 𝑦, 𝑧) =  1
𝑉
∑ ∑ ∑ |𝐹ℎ𝑘𝑙|𝑙𝑘ℎ 𝑒
−2𝜋𝑖(ℎ𝑥+𝑘𝑦+𝑙𝑧+𝑖𝜑ℎ𝑘𝑙), 
where j = each atom in the structure, fj = the scattering factor of each nth atom, V = 
volume of the unit cell and  hkl are the Miller’s indices of the reflection. 
However, the phase ϕ required to solve (7) is not recorded in the diffraction pattern and 
has to be obtained by other means. This is known as the “phase problem” in 
crystallography and several methods are available to solve this (Taylor 2003). The 
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structures presented in this thesis were solved by obtaining phases by molecular 
replacement. 
Molecular replacement 
This involves using a previously solved structure of a related protein (usually with 
>40% sequence identity) with the same protein fold to derive phases for the unsolved 
structure (McCoy et al. 2007; Evans & McCoy 2008). It first involves the generation of 
Patterson maps (8) that can be determined by both the experimental intensities and the 
model structure since it requires the square of the structure factor amplitudes |Fhkl|2 but 
not the phase.  
(8) (𝑢, 𝑣, 𝑤) =  ∑ |𝐹ℎ𝑘𝑙|2ℎ𝑘𝑙 𝑒−2𝜋𝑖(ℎ𝑢+𝑘𝑣+𝑙𝑤) ,  
where (u,v,w) are coordinates in Patterson space. 
The Patterson maps contain peaks relating every atom to every other atom in the 
structure, and the comparison of the maps of the model and unsolved structures allows 
the identification of the placement of the model in the experimental cell when the maps 
are closely correlated. This is first achieved by applying rotational functions to identify 
the correct model orientation, followed by translational functions to identify the correct 
coordinates within the unit cell. The phases derived from the model can then be used as 
an initial estimate to calculate electron density maps for building the new structure. 
Assessing data and model quality 
Historically, many methods exist to assess crystallographic data quality (Karplus & 
Diederichs 2015). The most recommended method currently is the calculation of the 
Pearson’s correlation coefficient between randomly chosen half data sets of measured 
intensities (CC1/2) and its variations, that detects the signal to noise ratio in the data and 
helps determine the maximum resolution cut-off.  
Likewise, the model quality is also assessed in multiple ways, from its fit to the 
experimental data to realistic bond angles and distances within atoms (Brown & 
Ramaswamy 2007; Wlodawer et al. 2008). To assess model fit to the experimental data, 
the structure factors calculated from the initial model (Fc) can be compared to the 
observed structure factors from the diffraction data (Fo). This is used to generate a 
difference electron density map using Fo-Fc, that indicates regions in the model that are 
poorly fitted, or missing atoms such as those belonging to cofactors and ligands. The 
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quality of the improved overall model is assessed by calculating the R-factor (9), which 
compares how well the model fits the original data. 
(9) 𝑅 = ∑ ||𝐹𝑜|−|𝐹𝑐||ℎ𝑘𝑙
∑ |𝐹𝑜|ℎ𝑘𝑙
, 
where hkl represents Miller’s indices for a unique reflection. 
To avoid the risk of over fitting the model to the data used in refinement, this value is 
compared to the Free R-factor (Rfree). Rfree is also calculated using (9), but with observed 
data that was previously set aside without use in the actual refinement process (usually 
randomly chosen 5% of unique reflections).  
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Appendix II: General background to phylogenetics and SSNs 
Molecular phylogenetics 
The evolution and diversity of proteins is most commonly studied through the use of 
phylogenetic trees. This section very briefly describes the basic principles behind the 
phylogenetic methods used in this thesis without going into mathematical detail. 
Comprehensive reviews on the subject include Yang & Rannala (2012), Blair & 
Murphy (2011) and Bromham (2016). 
Essentially, a molecular phylogenetic tree is an inference of the evolutionary 
relationships between DNA or protein sequences. A tree contains nodes or sequences 
that are connected by branches, where a node represents an event that creates new 
lineages and a branch represents the persistence of each lineage through time.  
Multiple sequence alignment (MSA) 
The first step in phylogenetic inference is the alignment of the sequences of interest. 
Several methods exist and the programs used in the work presented in this thesis are 
MUSCLE (Edgar 2004), MAFFT (Katoh & Standley 2013) and PROMALS3D (Pei et 
al. 2008). Both MUSCLE and MAFFT are based on the progressive alignment method 
that assumes that the input sequences share a common ancestor (Feng & Doolittle 
1987). First, pairwise alignments of sequences are made and used to calculate distance 
scores, which are then used to create a guide tree (Daugelaite et al. 2013). The multiple 
sequence alignment (MSA) is then built by gradually adding sequences according to the 
guide tree, where more similar sequences are added first followed by more distantly 
related sequences (Daugelaite et al. 2013). PROMALS3D is a structure-based alignment 
method that first clusters sequences to find representative sequences (Pei et al. 2008). 
The sequences of the representatives are aligned based on related solved 3-dimensional 
structures or if unavailable, based on the predicted protein secondary structure. The rest 
of the sequences are then added to each representative cluster to complete the MSA.  
In these methods, gaps are introduced into the alignment to account for sequence 
insertion and deletion events (indels), though the location of these are often ambiguous 
(Blair & Murphy 2011). Hence it has been shown that removal of ambiguously aligned 
regions with programs like Gblocks (Talavera & Castresana 2007) can lead to more 
accurate phylogenetic inference, especially if the MSA outputs of different programs are 
substantially different (Golubchik et al. 2007). 
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Generating phylogenetic trees by maximum likelihood 
Methods available for phylogenetic inference include those based on distance matrices, 
minimum evolution, maximum parsimony, maximum likelihood and Bayesian inference 
(Yang & Rannala 2012). Only the maximum likelihood methods relevant for the work 
presented in this thesis are discussed. 
Most maximum likelihood methods are computationally intensive. However, they are 
generally considered to give more accurate tree topologies and evolutionary inferences 
in comparison to distance based, minimum evolution and maximum parsimony 
methods, and produce trees similar in accuracy compared to methods based on Bayesian 
inference (Ogden & Rosenberg 2006). 
Maximum likelihood methods focus on finding the tree topology and branch lengths 
that maximise the likelihood or probability of observing the sequences in the dataset 
given a specific evolutionary model (Sullivan 2005). The tree making algorithm first 
finds multiple possible tree topologies using a fast distance-based method and optimises 
each tree by altering branch lengths and topology to increase the likelihood (Yang & 
Rannala 2012). These trees are then subject to further refinement through the same 
process until no trees with a greater likelihood is found (Tamura et al. 2011). The 
accuracy of the most likely tree depends on the correct selection of the best possible 
evolutionary model that fits the dataset, though often discrepancies in tree topology 
when using different models arise only at poorly supported nodes and rarely affect 
evolutionary conclusions (Ripplinger & Sullivan 2008). Currently, the most popular and 
accurate methods to generate maximum likelihood trees include the algorithms 
implemented by the MEGA phylogenetic suite (Tamura et al. 2013), PhyML (Guindon 
et al. 2010) and RAxML (Stamatakis 2014). However, their use is limited to relatively 
small data sets (usually less than 500 sequences) due to the large computational time 
required for the likelihood calculations (Yang & Rannala 2012).  
An approximation to the maximum likelihood method has been recently implemented 
by FastTree2, which is at least 100 times faster than true maximum likelihood methods 
(Price et al. 2010). The accuracy of this method is greater than distance based methods 
and comparable to the maximum likelihood program RAxML for large datasets (Liu et 
al. 2011). However, for smaller datasets, it is still preferable to use a true maximum 
likelihood approach (Price et al. 2010).  
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Similar to traditional maximum likelihood methods, FastTree first searches for an 
approximate tree topology using a fast distance based method (Price et al. 2010). This is 
followed by iterations to improve the tree topology by reducing the overall length of the 
tree. As in maximum likelihood methods, this tree is then further rearranged based on 
an evolutionary model to find the most likely tree by optimising branch topologies and 
lengths. However, this approximate maximum likelihood method differs from true 
maximum likelihood methods in a number of ways that decrease computational time 
(Price et al. 2010), such as abandoning the improvement of parts of the tree that have 
not improved in recent rounds and limiting the number of iterations of swapping branch 
topologies. In contrast, true likelihood methods continue the tree search until no further 
improvements in likelihood are observed. Hence the most likely tree may not be found 
this way, although it does provide a good approximation of a maximum likelihood tree. 
Assessing the accuracy of phylogenetic trees 
The most widely used and accepted method to calculate the accuracy of a tree is to 
generate bootstrap support values for each node (Felsenstein 1985). This involves the 
resampling of the original alignment to generate pseudo-alignments (usually at least 100 
alignments) containing randomly chosen sites. Trees are made based on these 
alignments using the same phylogenetic method and compared to the original tree to 
produce a percentage for the reproducibility of each node, assessing the stability of the 
tree topology. However, this process is extremely computationally intensive, especially 
when using maximum likelihood algorithms, and can often be misleading when fast 
evolving sequences are present due to their long branch lengths. Long branches are 
attracted to each other regardless of their true evolutionary history and are usually 
present as false deep branches (Felsenstein 1978; Philippe & Laurent 1998). In addition, 
poor MSAs in divergent protein families with low sequence identities or the presence of 
indels can also obscure the true evolutionary history, causing alternative possible tree 
topologies and poor bootstrap values (Ogden & Rosenberg 2006; Som 2015).  
Sequence similarity networks (SSNs) 
For the analysis of large diverse families containing the same protein fold, the 
relationships between contemporary proteins is often just as informative as their 
evolutionary trajectory, as it can shed light on the molecular mechanisms for functional 
adaptation. Sequence similarity networks (SSNs) are particularly useful for this since 
they do not draw any evolutionary inference, but rather makes pair-wise comparisons to 
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cluster proteins depending on their similarity (Atkinson et al. 2009). They are also much 
faster to produce than phylogenies, especially with the accessibility of the automated 
online server Enzyme Function Initiative Enzyme Similarity Tool (EFI-EST) (Gerlt et 
al. 2015), and have the added advantage of the ability to incorporate any available 
functional or taxonomic data into the network for visualization. 
In these networks, which can be visualised using the platform Cytoscape (Shannon et al. 
2003), a protein sequence is represented by a node, and its similarity to other proteins is 
represented by lines or edges connecting it with other nodes. Any measure of protein 
similarity can be used as edges, but the most popular parameter is the BLAST E-value, 
which is the probability of two proteins having a particular similarity score by chance 
(Altschul et al. 1997). As a smaller E-value means that two proteins are more similar, 
proteins form clusters that can be resolved at different E-value cut-offs using Cytoscape. 
These clusters indicate functional groups within the protein superfamily and have been 
shown to correlated well with experimentally determined functional data (Atkinson et 
al. 2009; Ahmed et al. 2015). This feature is also extremely useful in curating sequences 
for further phylogenetic analysis. Protein sequence sets can be restricted to particular 
families of interest and separated from closely related sequences with high similarity, 
which is a process that is not always intuitive or feasible when using a simple BLAST 
search. 
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